Neurociencia Traslacional (NeuroSur)

Dominguez-Mozo MI, Lopez-Mecandez D, Villar LM, Costa-Frossard L, VillarrubiaN, Aladro Y, Pilo B, Montalban X, Comabella M, Casanova-Peno I, Gonzalez-SuarezI, Martinez-Gines ML, Garcia-Dominguez JM, Garcia-Calvo E, Machuca-Marcos A,Luque-Garcia JL, Garcia-Martinez MA, Arroyo R, Alvarez-Lafuente R. Short-chainfatty acids in multiple sclerosis: Associated with disability, number of T2lesions, and inflammatory profile. Ann Clin Transl Neurol. 2025Mar;12(3):478-490. doi: 10.1002/acn3.52259. Epub 2025 Mar 3. PubMed PMID:40033709; PubMed Central PMCID: PMC11920722.

Freire M, Sopena B, Bravo S, Spuch C, Argibay A, Estevez M, Pena C, Naya M,Lama A, Gonzalez-Quintela A. Serum Proteomic Markers in Patients with SystemicSclerosis in Relation to Silica Exposure. J Clin Med. 2025 Mar 16;14(6):2019.doi: 10.3390/jcm14062019. PubMed PMID: 40142826; PubMed Central PMCID:PMC11942971.

Garcia-Colomo A, Lopez-Sanz D, Taguas I, Carrasco-Gomez M, Spuch C,Comis-Tuche M, Maestu F. Effects of Alzheimer’s disease plasma marker levels onmultilayer centrality in healthy individuals. Alzheimers Res Ther. 2025 Jan6;17(1):8. doi: 10.1186/s13195-024-01654-x. PubMed PMID: 39762903; PubMed CentralPMCID: PMC11702184.

Iglesias-Martinez-Almeida M, Campos-Rios A, Freiria-Martinez L,Rivera-Baltanas T, Rodrigues-Amorim D, Sanchez-Franco CM, Rodriguez-Tebar A,Peleteiro M, Comis-Tuche M, Gonzalez-Suarez I, Olivares JM, Lamas JA, Spuch C.Voltage-gated potassium channel isoform upregulation and functional alterationsin multiple sclerosis peripheral blood mononuclear cells. Int Immunopharmacol.2025 Nov 14;165:115476. doi: 10.1016/j.intimp.2025.115476. Epub 2025 Sep 3.PubMed PMID: 40907330.

Mas S, Julia L, Cuesta MJ, Crespo-Facorro B, Vazquez-Bourgon J, Spuch C,Gonzalez-Pinto A, Ibanez A, Usall J, Romero-Lopez-Alberca C, Catalan A, Mane A,Bernardo M. Applied pharmacogenetics to predict response to treatment of firstpsychotic episode: study protocol. Front Psychiatry. 2025 Jan 7;15:1497565. doi:10.3389/fpsyt.2024.1497565. eCollection 2024. PubMed PMID: 39839139; PubMedCentral PMCID: PMC11747510.

Perez-Sola V, Montes JM, Trillo-Calvo E, Gasull V, Garcia-Campayo J,Olivares-Diez JM, Berrocoso E, Mico JA, Aguera-Ortiz L. Consensus on thedetection and management of patients with depression and pain as an associatedsomatic symptom. Span J Psychiatry Ment Health. 2025 Jan-Mar;18(1):21-27. doi:10.1016/j.sjpmh.2023.10.002. Epub 2023 Nov 10. PubMed PMID: 37952640.

van der Horst MZ, de Boer N; CLOZIN collaborators; Okhuijsen-Pfeifer C, LuykxJJ. Determinants of patient satisfaction in clozapine users: results from theClozapine International Consortium (CLOZIN) [Tania Rivera]. Schizophrenia (Heidelb). 2025 Feb23;11(1):28. doi: 10.1038/s41537-025-00570-9. PubMed PMID: 39988615; PubMedCentral PMCID: PMC11847932.

Villacieros-Alvarez J, Espejo C, Arrambide G, Dinoto A, Mulero P, Rubio-FloresL, Nieto P, Alcala C, Meca-Lallana JE, Millan-Pascual J, Martinez-Garcia P,Bernard-Valnet R, Gonzalez-Suarez I, Orviz A, Tellez R, Navarro Canto L,Presas-Rodriguez S, Martinez-Yelamos S, Cuello JP, Alonso A, Pinar Morales R,Alvarez Bravo G, Benyahya L, Trouillet-Assant S, Dyon-Tafan V, Froment TiliketeC, Ruet A, Bourre B, Deschamps R, Papeix C, Maillart E, Kerschen P, Ayrignac X,Rovira A, Auger C, Audoin B, Montalban X, Tintore M, Mariotto S, Cobo-Calvo A,Marignier R. Profile and Usefulness of Serum Cytokines to Predict Prognosis inMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. NeurolNeuroimmunol Neuroinflamm. 2025 Mar;12(2):e200362. doi:10.1212/NXI.0000000000200362. Epub 2025 Jan 3. PubMed PMID: 39752619; PubMedCentral PMCID: PMC11702904.

Battino D, Tomson T, Bonizzoni E, Craig J, Perucca E, Sabers A, Thomas S,Alvestad S, Perucca P, Vajda F; EURAP Collaborators [MD Castro Vilanova]. Risk of Major CongenitalMalformations and Exposure to Antiseizure Medication Monotherapy. JAMA Neurol.2024 May 1;81(5):481-489. doi: 10.1001/jamaneurol.2024.0258. PubMed PMID:38497990; PubMed Central PMCID: PMC10949148.

Canto-Gomes J, Boleixa D, Teixeira C, Martins da Silva A, Gonzalez-Suarez I,Cerqueira J, Correia-Neves M, Nobrega C. Distinct disease-modifying therapies areassociated with different blood immune cell profiles in people withrelapsing-remitting multiple sclerosis. Int Immunopharmacol. 2024 Apr20;131:111826. doi: 10.1016/j.intimp.2024.111826. Epub 2024 Mar 10. PubMed PMID:38461632.

Cobo-Calvo A, Gomez-Ballesteros R, Orviz A, Diaz Sanchez M, Boyero S,Aguado-Valcarcel M, Sepulveda M, Rebollo P, Lopez-Laiz P, Maurino J, Tellez LaraN. Therapeutic inertia in the management of neuromyelitis optica spectrumdisorder. Front Neurol. 2024 Feb 21;15:1341473. doi: 10.3389/fneur.2024.1341473.eCollection 2024. PubMed PMID: 38450077; PubMed Central PMCID: PMC10915282.

Corripio I, Fraguas D, Garcia-Portilla MP, Olivares JM, Sierra P, Sanchez P.Functioning in schizophrenia: Recommendations of an expert panel. Schizophr Res.2024 Aug;270:317-322. doi: 10.1016/j.schres.2024.06.050. Epub 2024 Jul 3. PubMedPMID: 38964076.

Del Pino-Sedeno T, Gonzalez-Pacheco H, Gonzalez de Leon B, Serrano-Perez P,Acosta Artiles FJ, Valcarcel-Nazco C, Hurtado-Navarro I, Rodriguez Alvarez C,Trujillo-Martin MM; MAPDep Team. Effectiveness of interventions to improveadherence to antidepressant medication in patients with depressive disorders: acluster randomized controlled trial. Front Public Health. 2024 Apr 2;12:1320159.doi: 10.3389/fpubh.2024.1320159. eCollection 2024. PubMed PMID: 38633230; PubMedCentral PMCID: PMC11022850.

Diz-Chaves Y, Maastor Z, Spuch C, Lamas JA, Gonzalez-Matias LC, Mallo F.Glucagon-like peptide 1 receptor activation: anti-inflammatory effects in thebrain. Neural Regen Res. 2024 Aug 1;19(8):1671-1677. doi:10.4103/1673-5374.389626. Epub 2023 Dec 11. PubMed PMID: 38103230; PubMed CentralPMCID: PMC10960307.

Fernandez-Pereira C, Fernandez-Ceballos MLA, Olivares JM, Prieto-Gonzalez JM,Agis-Balboa RC. Neurofilament light chain plasma levels in major depressivedisorder: a brief research report. Front Psychiatry. 2024 Nov 14;15:1476248. doi:10.3389/fpsyt.2024.1476248. eCollection 2024. PubMed PMID: 39611129; PubMedCentral PMCID: PMC11602450.

Fernandez-Pereira C, Penedo MA, Alonso-Nunez A, Rivera-Baltanas T, Vieitez I,Prieto-Gonzalez JM, Vilarino-Vilarino MI, Olivares JM, Ortolano S, Agis-BalboaRC. Plasma IGFBP-3 and IGFBP-5 levels are decreased during acute manic episodesin bipolar disorder patients. Front Pharmacol. 2024 Apr 24;15:1384198. doi:10.3389/fphar.2024.1384198. eCollection 2024. PubMed PMID: 38720780; PubMedCentral PMCID: PMC11076695.

Filipa Costa-e-Sá , María Comís-Tuche , Carlos Spuch , Elisabete M.S. Castanheira , Sérgio R.S. Veloso. Sequential release of drugs from dual-delivery plasmonic nanogels containing lipid-gated mesoporous silica-coated gold nanorods. Journal of Drug Delivery Science and Technology 2024-04-28 , DOI:10.1016/j.jddst.2024.105723

Fonseca E, Olive-Cirera G, Martinez-Hernandez E, Guasp M, Naranjo L,Ruiz-Garcia R, Caballero E, Gonzalez-Alvarez V, Delgadillo V, Romeu G,Del-Prado-Sanchez C, Cabrera-Maqueda JM, Benito-Leon J, Iniguez C,Garcia-Dominguez JM, Calles C, Cano A, Alvarez-Bravo G, Gonzalez-Suarez I,Oreja-Guevara C, Ros M, Millan-Pascual J, Meca-Lallana JE, Borrega Canelo L,Martin-Martinez J, Palao M, Gracia J, Villaverde-Gonzalez R, Llufriu S, Blanco Y,Saiz A, Dalmau J, Sepulveda M, Armangue T; Spanish MOGAD study group.Investigating the 2023 MOGAD Criteria in Children and Adults With MOG-AntibodyPositivity Within and Outside Attacks. Neurology. 2024 Sep 24;103(6):e209682.doi: 10.1212/WNL.0000000000209682. Epub 2024 Aug 27. PubMed PMID: 39190859.

Garcia-Colomo A, Lopez-Sanz D, Stam CJ, Hillebrand A, Carrasco-Gomez M, SpuchC, Comis-Tuche M, Maestu F. Minimum spanning tree analysis of unimpairedindividuals at risk of Alzheimer’s disease. Brain Commun. 2024 Aug20;6(5):fcae283. doi: 10.1093/braincomms/fcae283. eCollection 2024. PubMed PMID:39229485; PubMed Central PMCID: PMC11369931.

Garcia-Colomo A, Nebreda A, Carrasco-Gomez M, de Frutos-Lucas J,Ramirez-Torano F, Spuch C, Comis-Tuche M, Bruna R, Alfonsin S, Maestu F.Longitudinal changes in the functional connectivity of individuals at risk ofAlzheimer’s disease. Geroscience. 2024 Jun;46(3):2989-3003. doi:10.1007/s11357-023-01036-5. Epub 2024 Jan 4. PubMed PMID: 38172488; PubMedCentral PMCID: PMC11009204.

Gimenez-Palomo A, Fico G, Borras R, Sague-Vilavella M, Gomez-Ramiro M, ForteaA, Fortea L, Vazquez M, Vieta E. Increasing prevalence of self-harm, suicidalbehavior and suicidal ideation throughout a three-year period in the context ofCOVID-19 pandemic in Spain. Psychiatry Res. 2024 Sep;339:116015. doi:10.1016/j.psychres.2024.116015. Epub 2024 Jun 25. PubMed PMID: 38943785.

Iglesias-Martinez-Almeida M, Campos-Rios A, Freiria-Martinez L,Rivera-Baltanas T, Rodrigues-Amorim D, Diz-Chaves Y, Comis-Tuche M,Fernandez-Palleiro P, Rodriguez-Jamardo C, Ramos-Garcia S, Rodriguez-Tebar A, DelCarmen Vallejo-Curto M, Campos-Perez JA, Lopez-Garcia M, de Las Heras E,Garcia-Caballero A, Olivares JM, Lamas JA, Spuch C. Characterization andmodulation of voltage-gated potassium channels in human lymphocytes inschizophrenia. Schizophr Res. 2024 Aug;270:260-272. doi:10.1016/j.schres.2024.06.034. Epub 2024 Jun 29. PubMed PMID: 38944972.

Oliveras C, Bruguera P, Cordero Torres I, Millan Hernandez A, Pons MT, GuzmanCortez PR, Gomez-Ramiro M, Vazquez Vallejo M, Salgado E, Asenjo Romero M, VietaE, Gual A, Lopez-Pelayo H, Balcells-Olivero M. Another Round: Influence ofAlcohol-Related Conditions and Other Drug Use-Related Disorders in EmergencyDepartment Frequent Use – A Single-Site Matched Case-Control Study in Spain. EurAddict Res. 2024;30(5):275-287. doi: 10.1159/000538987. Epub 2024 Jul 26. PubMedPMID: 39068928; PubMed Central PMCID: PMC11702512.

Oliveras C, Bruguera P, Cordero-Torres I, Millan-Hernandez A, Pons-Cabrera MT,Guzman Cortez PR, Gomez-Ramiro M, Vazquez M, Borras R, Asenjo-Romero M, Vieta E,Gual A, Lopez-Pelayo H, Balcells-Olivero M. Effects of alcohol-related problemson the costs of frequent emergency department use: an economic analysis of acase-control study in Spain. Front Public Health. 2024 Dec 3;12:1322327. doi:10.3389/fpubh.2024.1322327. eCollection 2024. PubMed PMID: 39697278; PubMedCentral PMCID: PMC11653189.

Oreja-Guevara C, Gonzalez-Suarez I, Bilbao MM, Gomez-Palomares JL, RodriguezCH, Rabanal A, Benito YA. Multiple sclerosis: Pregnancy, fertility, and assistedreproductive technology-a review. Mult Scler Relat Disord. 2024 Dec;92:105893.doi: 10.1016/j.msard.2024.105893. Epub 2024 Sep 21. PubMed PMID: 39393162.

Segalas C, Cernadas E, Puialto M, Fernandez-Delgado M, Arrojo M, Bertolin S,Real E, Menchon JM, Carracedo A, Tubio-Fungueirino M, Alonso P, Fernandez-PrietoM. Cognitive and clinical predictors of a long-term course in obsessivecompulsive disorder: A machine learning approach in a prospective cohort study. JAffect Disord. 2024 Apr 1;350:648-655. doi: 10.1016/j.jad.2024.01.157. Epub 2024Jan 19. PubMed PMID: 38246282.

Serrano-Perez P, Lugo-Marin J, Palma-Alvarez RF, Volberg R, Jimenez-Murcia S,Ramos-Quiroga JA, Grau-Lopez L. Spanish validation of the Brief Problem GamblingScreen in patients with substance use disorders. Adicciones. 2024 Jun1;36(2):145-154. doi: 10.20882/adicciones.1754. English, Spanish. PubMed PMID:36200231.

Serrano-Perez P, Rivero-Santana A, Daigre-Blanco C, Palma-Alvarez RF,Nistal-Franco I, Ramos-Quiroga JA, Grau-Lopez L. Correlates of ControlPreferences, Participation in Decision-making and Activation in Patients withSubstance Use Disorder. Actas Esp Psiquiatr. 2024 Jun;52(3):192-203. doi:10.62641/aep.v52i3.1598. PubMed PMID: 38863054; PubMed Central PMCID:PMC11188765.

Tellez-Lara N, Gomez-Ballesteros R, Sepulveda M, Orviz A, Diaz-Sanchez M,Boyero S, Aguado-Valcarcel M, Cobo-Calvo A, Lopez-Laiz P, Rebollo P, Maurino J.Preferences for neuromyelitis optica spectrum disorder treatments: A conjointanalysis with neurologists in Spain. Mult Scler Relat Disord. 2024 Aug;88:105732.doi: 10.1016/j.msard.2024.105732. Epub 2024 Jun 17. PubMed PMID: 38936324.

Vazquez Doce A, De Leon Garcia FJ, Mena A, Ortiz-Fernandez L, Spottorno MP,Medina F, Maisonobe P, Herrera A, Garcia I, Juan-Garcia FJ; RELIEF investigatorsgroup. Assessment of pain relief after four botulinum toxin A injection cycles inpatients with post-stroke lower limb spasticity: A prospective, observationalstudy. Rehabilitacion (Madr). 2024 Jul-Sep;58(3):100856. doi:10.1016/j.rh.2024.100856. Epub 2024 May 24. PubMed PMID: 38795502.

Veloso, S. R. S., Vázquez-González, M., Spuch, C., Freiría-Martínez, L., Comís-Tuche, M., Iglesias-Martínez-Almeida, M., Rivera-Baltanás, T., Hilliou, L., Amorim, Amaral, Coutinho, P. J. G., Ferreira, P. M. T., Castanheira, E. M. S., & Correa-Duarte, M. A. (2024). An Injectable Composite Co-Assembled Dehydropeptide-Based Magnetic/Plasmonic Lipogel for Multimodal Cancer Therapy. Advanced Functional Materials. 2024;34(38). https://doi.org/10.1002/ADFM.202402926

Joaquín Sánchez Herrero, José Luis Maciñeiras Montero (Coord.), Pablo Vicente Alba (Coord.), Carmen María Labandeira Guerra et al. Atención al ICTUS. Guía Clínica. Hospital Álvaro Cunqueiro. Área Sanitaria de Vigo, 2024.

Canto-Gomes J, Da Silva-Ferreira S, Silva CS, Boleixa D, Martins da Silva A,Gonzalez-Suarez I, Cerqueira JJ, Correia-Neves M, Nobrega C. People with PrimaryProgressive Multiple Sclerosis Have a Lower Number of Central Memory T Cells andHLA-DR+ Tregs. Cells. 2023 Jan 29;12(3):439. doi:10.3390/cells12030439. PubMed PMID: 36766781; PubMed Central PMCID: PMC9913799.

Dominguez-Mozo MI, Gonzalez-Suarez I, Villar LM, Costa-Frossard L, VillarrubiaN, Aladro Y, Pilo B, Montalban X, Comabella M, Casanova-Peno I, Martinez-GinesML, Garcia-Dominguez JM, Garcia-Martinez MA, Arroyo R, Alvarez-Lafuente R.Teriflunomide and Epstein-Barr virus in a Spanish multiple sclerosis cohort:in vivo antiviral activity and clinical response. Front Immunol. 2023Sep 29;14:1248182. doi: 10.3389/fimmu.2023.1248182. eCollection 2023. PubMedPMID: 37841253; PubMed Central PMCID: PMC10570817.

Fernandez-Pereira C, Penedo MA, Rivera-Baltanas T, Perez-Marquez T,Alves-Villar M, Fernandez-Martinez R, Veiga C, Salgado-Barreira A,Prieto-Gonzalez JM, Ortolano S, Olivares JM, Agis-Balboa RC. Protein PlasmaLevels of the IGF Signalling System Are Altered in Major Depressive Disorder. IntJ Mol Sci. 2023 Oct 17;24(20):15254. doi: 10.3390/ijms242015254. PubMed PMID:37894932; PubMed Central PMCID: PMC10607273.

Fico G, Isayeva U, De Prisco M, Oliva V, Sole B, Montejo L, Grande I, ArbeloN, Gomez-Ramiro M, Pintor L, Carpiniello B, Manchia M, Vieta E, Murru A.Psychotropic drug repurposing for COVID-19: A Systematic Review andMeta-Analysis. Eur Neuropsychopharmacol. 2023 Jan;66:30-44. doi:10.1016/j.euroneuro.2022.10.004. Epub 2022 Oct 20. PubMed PMID: 36399837; PubMedCentral PMCID: PMC9581805.

Fico G, Oliva V, De Prisco M, Fortea L, Fortea A, Gimenez-Palomo A, Anmella G,Hidalgo-Mazzei D, Vazquez M, Gomez-Ramiro M, Carreras B, Murru A, Radua J,Mortier P, Vilagut G, Amigo F, Ferrer M, Garcia-Mieres H, Vieta E, Alonso J.Anxiety and depression played a central role in the COVID-19 mental distress: Anetwork analysis. J Affect Disord. 2023 Oct 1;338:384-392. doi:10.1016/j.jad.2023.06.034. Epub 2023 Jun 17. PubMed PMID: 37336249; PubMedCentral PMCID: PMC10276655.

Fortea A, Fortea L, Gomez-Ramiro M, Fico G, Gimenez-Palomo A, Sague-VilavellaM, Pons MT, Vazquez M, Baldaqui N, Colomer L, Fernandez TM, Gutierrez-Arango F,Llobet M, Pujal E, Lazaro L, Vieta E, Radua J, Baeza I. Upward trends in eatingdisorders, self-harm, and suicide attempt emergency admissions in femaleadolescents after COVID-19 lockdown. Span J Psychiatry Ment Health. 2023 Oct5:S2950-2853(23)00036-4. doi: 10.1016/j.sjpmh.2023.09.003. Online ahead of print.PubMed PMID: 38591827.

Freiria-Martinez L, Iglesias-Martinez-Almeida M, Rodriguez-Jamardo C,Rivera-Baltanas T, Comis-Tuche M, Rodrigues-Amorim D, Fernandez-Palleiro P,Blanco-Formoso M, Alvarez-Chaver P, Diz-Chaves Y, Gonzalez-Freiria N,Martin-Forero-Maestre M, Fernandez-Feijoo CD, Suarez-Albo M, Fernandez-LorenzoJR, Guisan AC, Olivares JM, Spuch C. Proteomic analysis of exosomes derived fromhuman mature milk and colostrum of mothers with term, late preterm, or verypreterm delivery. Anal Methods. 2023 Sep 28;15(37):4905-4917. doi:10.1039/d3ay01114c. PubMed PMID: 37718950.

Freiria-Martinez L, Iglesias-Martinez-Almeida M, Rodriguez-Jamardo C,Rivera-Baltanas T, Comis-Tuche M, Rodrigues-Amorim D, Fernandez-Palleiro P,Blanco-Formoso M, Diz-Chaves Y, Gonzalez-Freiria N, Suarez-Albo M,Martin-Forero-Maestre M, Duran Fernandez-Feijoo C, Fernandez-Lorenzo JR,Concheiro Guisan A, Olivares JM, Spuch C. Human Breast Milk microRNAs, PotentialPlayers in the Regulation of Nervous System. Nutrients. 2023 Jul 24;15(14):3284.doi: 10.3390/nu15143284. PubMed PMID: 37513702; PubMed Central PMCID:PMC10384760.

Gil-Perotin S, Reddam S, Gonzalez-Mingot C, Gil-Sanchez A, Gonzalez-Suarez I,Peralta S, Escriva P, Barea-Moya L, Sanchez-Sanchez B. Reliability, validity anddistribution of the Spanish female sexual function index in women with relapsingmultiple sclerosis. BMC Womens Health. 2023 Dec 11;23(1):663. doi:10.1186/s12905-023-02811-4. PubMed PMID: 38082275; PubMed Central PMCID:PMC10712072.

Lopez-Caneda C, Perez-Haro MJ, Sanchez-Franco C, Alvarez-Rodriguez E,Aguado-Valcarcel M, Marcos-Bobillo M, Gonzalez-Suarez I. Real-world persistenceto first-line DMTs in relapsing-remitting multiple sclerosis. Mult Scler RelatDisord. 2023 Oct;78:104909. doi: 10.1016/j.msard.2023.104909. Epub 2023 Jul 22.PubMed PMID: 37603928.

Oreja-Guevara C, Rabanal A, Rodriguez CH, Benito YA, Bilbao MM,Gonzalez-Suarez I, Gomez-Palomares JL. Assisted Reproductive Techniques inMultiple Sclerosis: Recommendations from an Expert Panel. Neurol Ther. 2023Apr;12(2):427-439. doi: 10.1007/s40120-023-00439-y. Epub 2023 Feb 7. PubMed PMID:36746871; PubMed Central PMCID: PMC10043068.

Perez-Rodriguez D, Penedo MA, Rivera-Baltanas T, Pena-Centeno T, Burkhardt S,Fischer A, Prieto-Gonzalez JM, Olivares JM, Lopez-Fernandez H, Agis-Balboa RC.MiRNA Differences Related to Treatment-Resistant Schizophrenia. Int J Mol Sci.2023 Jan 18;24(3):1891. doi: 10.3390/ijms24031891. PubMed PMID: 36768211; PubMedCentral PMCID: PMC9916039.

Rodriguez Pulido F, Caballero Estebaranz N, Garcia Caballero AA, GonzalezDavila E, Leon Palacin C, Hernandez Alvarez de Sotomayor MDC, Lopez Reig S,Vilchez de Leon PI. Social cognition and emotional rehabilitation in participantswith schizofrenia. Front Psychiatry. 2023 Nov 8;14:1250933. doi:10.3389/fpsyt.2023.1250933. eCollection 2023. PubMed PMID: 38025483; PubMedCentral PMCID: PMC10663374.

Sancho-Saldana A, Gil-Sanchez A, Gonzalez-Mingot C, Peralta S, Solana MJ,Torres P, Juanes A, Quibus L, Ruiz E, Sanpedro E, Quirant-Sanchez B,Martinez-Caceres E, Ramo Tello C, Presas-Rodriguez S, Garcia Rubio S, Baron BP,Ramio-Torrenta L, Sotoca J, Gonzalez-Suarez I, Eichau S, Prieto-Gonzalez JM,Blasco Quilez MR, Sabin-Munoz J, Sanchez-Lopez AJ, Llorens Calatayud G, Calles C,Sempere AP, Garces M, Carmona O, Moral E, Hervas JV, Blanco Y, Sola-Valls N,Tellez Lara N, Forero L, Brieva L. Seroprevalence of SARS-CoV-2 in Patients withMultiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study. JClin Med. 2023 Nov 23;12(23):7243. doi: 10.3390/jcm12237243. PubMed PMID:38068295; PubMed Central PMCID: PMC10707506.

Serrano-Perez P, Rivero-Santana A, Daigre-Blanco C, Palma-Alvarez RF,Nistal-Franco I, Antoni Ramos-Quiroga J, Grau-Lopez L. Shared decision making inpatients with substance use disorders: A one-year follow-up study. PsychiatryRes. 2023 Nov;329:115540. doi: 10.1016/j.psychres.2023.115540. Epub 2023 Oct 11.PubMed PMID: 37857131.

van der Horst MZ, Meijer Y, de Boer N, Guloksuz S, Hasan A, Siskind D, WagnerE; CLOZIN consortium; Okhuijsen-Pfeifer C, Luykx JJ, CLOZIN consortium [C Spuch] . Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies ofclozapine-associated adverse drug reactions. Psychiatry Res. 2023 Dec;330:115539.doi: 10.1016/j.psychres.2023.115539. Epub 2023 Oct 11. PubMed PMID: 37988817.

Villanueva V, Santos-Carrasco D, Cabezudo-Garcia P, Gomez-Ibanez A, Garces M,Serrano-Castro P, Castro-Vilanova MD, Sayas D, Lopez-Gonzalez FJ,Rodriguez-Osorio X, Torres-Gaona G, Saiz-Diaz RA, Hampel KG, Martinez-Ferri M,Aguilar-Amat MJ, Mercedes-Alvarez B, Garcia-Morales V, Del Villar-Igea A,Massot-Tarrus A, Rodriguez-Uranga JJ. Real-world safety and effectiveness ofcenobamate in patients with focal onset seizures: Outcomes from an ExpandedAccess Program. Epilepsia Open. 2023 Sep;8(3):918-929. doi: 10.1002/epi4.12757.Epub 2023 May 21. PubMed PMID: 37149853; PubMed Central PMCID: PMC10472366.

De las Heras Liñero ME, Triñanes Pego, Y (Coord.) Alonso López J, Alvarez Ariza M, Atienza Merino G, Castro Bouzas M, Bugarín González R; Fernández Silva M, González García A, Sanmartín Feijóo S. Grupo de Trabajo de revisión de la Guía de Práctica Clínica sobre el manejo de la Depresión en el adulto 2014. Revisión de la Guía de Práctica Clínica sobre el manejo de la Depresión en el adulto (2014) del Programa de GPC en el SNS. Ministerio de Sanidad. Agencia Gallega para la Gestión del Conocimiento en Salud, ACIS, Unidad de Asesoramiento Cientí co-Técnico, Avalia-t; 2023. Guías de Práctica Clínica en el SNS. http://hdl.handle.net/20.500.11940/17561

Alvarez-Rodriguez E, Sanchez-Franco CM, Perez-Haro MJ, Bello-Otero L,Aguado-Valcarcel M, Gonzalez-Suarez I. Development of a scale for the evaluationof the quality of the shared decision process in multiple sclerosis patients.PLoS One. 2022 May 13;17(5):e0268125. doi: 10.1371/journal.pone.0268125.eCollection 2022. PubMed PMID: 35560185; PubMed Central PMCID: PMC9106213.

Canto-Gomes J, Silva CS, Rb-Silva R, Boleixa D, da Silva AM, Cheynier R, CostaP, Gonzalez-Suarez I, Correia-Neves M, Cerqueira JJ, Nobrega C. Low Memory TCells Blood Counts and High Naive Regulatory T Cells Percentage at RelapsingRemitting Multiple Sclerosis Diagnosis. Front Immunol. 2022 May 30;13:901165.doi: 10.3389/fimmu.2022.901165. eCollection 2022. PubMed PMID: 35711452; PubMedCentral PMCID: PMC9196633.

Daigre C, Grau-Lopez L, Palma-Alvarez RF, Perea-Ortueta M, Sorribes-Puertas M,Serrano-Perez P, Quesada M, Segura L, Coronado M, Ramos-Quiroga JA, Colom J;XAD-COVID19-Group. A Multicenter Study on the Impact of Gender, Age, and DualDiagnosis on Substance Consumption and Mental Health Status in OutpatientsTreated for Substance Use Disorders During COVID-19 Lockdown. J Dual Diagn. 2022Apr-Jun;18(2):71-80. doi: 10.1080/15504263.2022.2051110. Epub 2022 Mar 24. PubMedPMID: 35324373.

Diz-Chaves Y, Mastoor Z, Spuch C, Gonzalez-Matias LC, Mallo F.Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain inNeurodegenerative Diseases. Int J Mol Sci. 2022 Aug 24;23(17):9583. doi:10.3390/ijms23179583. PubMed PMID: 36076972; PubMed Central PMCID: PMC9455625.

Facal D, Spuch C, Valladares-Rodriguez S. New Trends in Cognitive Aging andMild Cognitive Impairment. Geriatrics (Basel). 2022 Aug 1;7(4):80. doi:10.3390/geriatrics7040080. PubMed PMID: 36005256; PubMed Central PMCID:PMC9408095.

Fernandez-Pereira C, Penedo MA, Rivera-Baltanas T, Fernandez-Martinez R,Ortolano S, Olivares JM, Agis-Balboa RC. Insulin-like Growth Factor 2 (IGF-2) andInsulin-like Growth Factor Binding Protein 7 (IGFBP-7) Are Upregulated afterAtypical Antipsychotics in Spanish Schizophrenia Patients. Int J Mol Sci. 2022Aug 24;23(17):9591. doi: 10.3390/ijms23179591. PubMed PMID: 36076984; PubMedCentral PMCID: PMC9455262.

Fernandez-Velasco JI, Monreal E, Kuhle J, Meca-Lallana V, Meca-Lallana J,Izquierdo G, Oreja-Guevara C, Gascon-Gimenez F, Sainz de la Maza S, Walo-DelgadoPE, Lapuente-Suanzes P, Maceski A, Rodriguez-Martin E, Roldan E, Villarrubia N,Saiz A, Blanco Y, Diaz-Perez C, Valero-Lopez G, Diaz-Diaz J, Aladro Y, Brieva L,Iniguez C, Gonzalez-Suarez I, Rodriguez de Antonio LA, Garcia-Dominguez JM, SabinJ, Llufriu S, Masjuan J, Costa-Frossard L, Villar LM. Baseline InflammatoryStatus Reveals Dichotomic Immune Mechanisms Involved In Primary-ProgressiveMultiple Sclerosis Pathology. Front Immunol. 2022 Mar 21;13:842354. doi:10.3389/fimmu.2022.842354. eCollection 2022. PubMed PMID: 35386690; PubMedCentral PMCID: PMC8977599.

Gonzalez de Leon B, Del Pino-Sedeno T, Serrano-Perez P, Rodriguez Alvarez C,Bejarano-Quisoboni D, Trujillo-Martin MM. Effectiveness of interventions toimprove medication adherence in adults with depressive disorders: ameta-analysis. BMC Psychiatry. 2022 Jul 20;22(1):487. doi:10.1186/s12888-022-04120-w. PubMed PMID: 35858887; PubMed Central PMCID:PMC9301839.

Grau-Lopez L, Daigre C, Palma-Alvarez RF, Sorribes-Puertas M, Serrano-Perez P,Quesada-Franco M, Segura L, Coronado M, Ramos-Quiroga JA, Colom J;XAD-COVID19-Group. COVID-19 Lockdown and Consumption Patterns among Substance UseDisorder Outpatients: A Multicentre Study. Eur Addict Res. 2022;28(4):243-254.doi: 10.1159/000521425. Epub 2022 Jan 17. PubMed PMID: 35038702; PubMed CentralPMCID: PMC8805052.

Lado-Codesido M, Sanchez-Reales S, Caballero-Pelaez C, Iglesias-Gaspar MT,Lado MJ, Garcia-Caballero A, Lahera G. Emotion recognition through Spanishprosody in people with schizophrenia. Actas Esp Psiquiatr. 2022Jul;50(4):196-205. Epub 2022 Jul 1. PubMed PMID: 35867486.

Lopez-Soley E, Meca-Lallana JE, Llufriu S, Blanco Y, Gomez-Ballesteros R,Maurino J, Perez-Miralles F, Forero L, Calles C, Martinez-Gines ML,Gonzalez-Suarez I, Boyero S, Romero-Pinel L, Sempere AP, Meca-Lallana V, QuerolL, Costa-Frossard L, Sepulveda M, Solana E. Cognitive Performance andHealth-Related Quality of Life in Patients with Neuromyelitis Optica SpectrumDisorder. J Pers Med. 2022 May 2;12(5):743. doi: 10.3390/jpm12050743. PubMedPMID: 35629165; PubMed Central PMCID: PMC9146457.

Meca-Lallana JE, Gomez-Ballesteros R, Perez-Miralles F, Forero L, Sepulveda M,Calles C, Martinez-Gines ML, Gonzalez-Suarez I, Boyero S, Romero-Pinel L, SempereAP, Meca-Lallana V, Querol L, Costa-Frossard L, Prefasi D, Maurino J. Impact ofNeuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients’Perspective: An Observational Cross-Sectional Study. Neurol Ther. 2022Sep;11(3):1101-1116. doi: 10.1007/s40120-022-00356-6. Epub 2022 May 6. PubMedPMID: 35524037; PubMed Central PMCID: PMC9075919.

Olivares JM, Fagiolini A. Long-Term Real-World Effectiveness of AripiprazoleOnce-Monthly. Treatment Persistence and Its Correlates in the Italian and SpanishClinical Practice: A Pooled Analysis. Front Psychiatry. 2022 Apr 28;13:877867.doi: 10.3389/fpsyt.2022.877867. eCollection 2022. PubMed PMID: 35573364; PubMedCentral PMCID: PMC9096029.

Palma-Alvarez RF, Daigre C, Ros-Cucurull E, Perea-Ortueta M, Serrano-Perez P,Ortega-Hernandez G, Ramos-Quiroga JA, Grau-Lopez L, Roncero C. Confirmatoryfactor analysis of 20-item toronto alexithymia scale in spanish patients withsubstance use disorder. Actas Esp Psiquiatr. 2022 Sep;50(5):208-215. Epub 2022Sep 1. PubMed PMID: 36273380.

Pinon-Blanco A, Vergara-Moragues E, Gutierrez-Martinez O, Fernandez-PalleiroP, Rodrigues S, Rodrigues-Amorim D, Lage-Lopez MT, Gonzalez-Lopez A, Velasquez T,Amorim M, Lloves-Moratinos M, Vieitez-Fernandez I, Sabio-Fernandez G,Grana-Torralba R, Vilar-Diaz V, Carrera-Machado I, Cancelo-Martinez J, FerreiraA, Cardoso S, Rivera-Baltanas T, Otero-Lamas F, Olivares JM, Spuch C. Efficacy ofthe Therapeutic Game «Trisquel» in the Treatment of Patients WithSubstance-Related Disorders Randomized Clinical Study. Front Psychiatry. 2022 May2;13:864511. doi: 10.3389/fpsyt.2022.864511. eCollection 2022. PubMed PMID:35586410; PubMed Central PMCID: PMC9108152.

Rodrigues-Amorim D, Rivera-Baltanás T, Fernández-Palleiro P, Iglesias-Martínez-Almeida M, Freiría-Martínez L, Jarmardo-Rodriguez C, Del Carmen Vallejo-Curto M, Álvarez-Ariza M, López-García M, de Las Heras E, García-Caballero A, Olivares JM, Spuch C. Changes in the Brain Extracellular Matrix Composition in schizophrenia: A Pathophysiological Dysregulation and a Potential Therapeutic Target. Cell Mol Neurobiol. 2022 Aug;42(6):1921–32. PMID: 33712885. DOI: 10.1007/s10571-021-01073-8. http://www.ncbi.nlm.nih.gov/pubmed/33712885
Enlace

Spuch C, Lopez-Garcia M, Rivera-Baltanas T, Cabrera-Alvargonzalez JJ, Gadh S,Rodrigues-Amorim D, Alvarez-Estevez T, Mora A, Iglesias-Martinez-Almeida M,Freiria-Martinez L, Perez-Rodriguez M, Perez-Gonzalez A, Lopez-Dominguez A,Longueira-Suarez MR, Sousa-Dominguez A, Araujo-Ameijeiras A, Mosquera-RodriguezD, Crespo M, Vila-Fernandez D, Regueiro B, Olivares JM. Efficacy and Safety ofLithium Treatment in SARS-CoV-2 Infected Patients. Front Pharmacol. 2022 Apr14;13:850583. doi: 10.3389/fphar.2022.850583. eCollection 2022. PubMed PMID:35496309; PubMed Central PMCID: PMC9046673.

Veloso SRS, Tiryaki E, Spuch C, Hilliou L, Amorim CO, Amaral VS, Coutinho PJG,Ferreira PMT, Salgueirino V, Correa-Duarte MA, Castanheira EMS. Tuning the drugmultimodal release through a co-assembly strategy based on magnetic gels.Nanoscale. 2022 Apr 7;14(14):5488-5500. doi: 10.1039/d1nr08158f. PubMed PMID:35332904.

Álvarez M, Bilbao E, González A, Guitián D, Jiménez I, Martínez M, Grupo de trabajo del OPBE. Evaluación y manejo clínico de las autolesiones en la adolescencia: protocolo basado en la evidencia. Madrid: Ministerio de Sanidad; Santiago de Compostela: Agencia Gallega para la Gestión de Conocimiento en Salud, ACIS, Unidad de Asesoramiento Científico-técnico, Avalia-t; 2022. https://doi.org/10.46995/pr_4

Amoretti S, Verdolini N, Mezquida G, Rabelo-da-Ponte FD, Cuesta MJ, Pina-Camacho L, Gomez-Ramiro M, De-la-Cámara C, González-Pinto A, Díaz-Caneja CM, Corripio I, Vieta E, de la Serna E, Mané A, Solé B, Carvalho AF, Serra M, Bernardo M. Identifying clinical clusters with distinct trajectories in first-episode psychosis through an unsupervised machine learning technique. Eur Neuropsychopharmacol. 2021 Jun;47:112–29. PMID: 33531261. DOI: 10.1016/j.euroneuro.2021.01.095. http://www.ncbi.nlm.nih.gov/pubmed/33531261
Enlace

Baldaquí N, Anmella G, Gómez-Ramiro M, Guasp M, Mesa A, Parellada E. Thyrotoxic Psychosis Associated With Amiodarone. J Clin Psychopharmacol. 2021;41(3):342–4. PMID: 33734169. DOI: 10.1097/JCP.0000000000001375. http://www.ncbi.nlm.nih.gov/pubmed/33734169
Enlace

Borrajo A, Spuch C, Penedo MA, Olivares JM, Agís-Balboa RC. Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis. Ann Med. 2021;53(1):43–69. PMID: 32841065. DOI: 10.1080/07853890.2020.1814962. http://www.ncbi.nlm.nih.gov/pubmed/32841065
Enlace

Borrajo López A, Penedo MA, Rivera-Baltanas T, Pérez-Rodríguez D, Alonso-Crespo D, Fernández-Pereira C, Olivares JM, Agís-Balboa RC. Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders? Biomedicines. 2021 Jul;9(8):925. DOI: 10.3390/biomedicines9080925. https://www.mdpi.com/2227-9059/9/8/925
Enlace

Catalan A, García L, Sanchez-Alonso S, Gil P, Díaz-Marsá M, Olivares JM, Rivera-Baltanás T, Pérez-Martín J, Torres MÁG, Ovejero S, Tost M, Bergé D, Rodríguez A, Labad J. Early intervention services, patterns of prescription and rates of discontinuation of antipsychotic treatment in first-episode psychosis. Early Interv Psychiatry. 2021 Dec;15(6):1584–94. PMID: 33289317. DOI: 10.1111/eip.13098. http://www.ncbi.nlm.nih.gov/pubmed/33289317
Enlace

Coelho-Guimarães N, Garcia-Casal JA, Díaz-Mosquera S, Álvarez-Ariza M, Martínez-Abad F, Mateos-Álvarez R. [Validation of RUDAS: A screening tool for dementia in Primary Health Care settings]. Aten primaria. 2021;53(5):102024. PMID: 33812318. DOI: 10.1016/j.aprim.2021.102024. http://www.ncbi.nlm.nih.gov/pubmed/33812318
Enlace

Facal D, Burgo C, Spuch C, Gaspar P, Campos-Magdaleno M. Cognitive Frailty: AnUpdate. Front Psychol. 2021 Dec 16;12:813398. doi: 10.3389/fpsyg.2021.813398.eCollection 2021. PubMed PMID: 34975703; PubMed Central PMCID: PMC8717771.

Fernández-Velasco JI, Kuhle J, Monreal E, Meca-Lallana V, Meca-Lallana J, Izquierdo G, Gascón-Giménez F, Sainz de la Maza S, Walo-Delgado PE, Maceski A, Rodríguez-Martín E, Roldán E, Villarrubia N, Saiz A, Blanco Y, Sánchez P, Carreón-Guarnizo E, Aladro Y, Brieva L, Íñiguez C, González-Suárez I, Rodríguez de Antonio LA, Masjuan J, Costa-Frossard L, Villar LM. Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS. Neurol Neuroimmunol neuroinflammation. 2021;8(2):e940. PMID: 33408167. DOI: 10.1212/NXI.0000000000000940. http://www.ncbi.nlm.nih.gov/pubmed/33408167
Enlace

Fico G, Anmella G, Gomez-Ramiro M, de Miquel C, Hidalgo-Mazzei D, Manchia M, Alda M, Gonzalez-Pinto A, Carvalho AF, Vieta E, Murru A. Duration of untreated illness and bipolar disorder: time for a new definition? Results from a cross-sectional study. J Affect Disord. 2021;294:513–20. PMID: 34330047. DOI: 10.1016/j.jad.2021.07.062. http://www.ncbi.nlm.nih.gov/pubmed/34330047
Enlace

Fonseca E, Campos Blanco DM, Castro Vilanova MD, Garamendi Í, Gómez-Eguilaz M, Pérez Díaz H, Poza JJ, Querol-Pascual MR, Quiroga-Subirana P, Rodríguez-Osorio X, Zurita Santamaría J, Centeno M, Díaz de Cerio Julián L, Estévez-María JC, Martínez Agredano P, Mauri Llerda JÁ, Sala-Padró J, Falip M, Abraira L, Santamarina E, Seijo-Raposo I, Quintana M, Toledo M. Relationship between sleep quality and cognitive performance in patients with epilepsy. Epilepsy Behav. 2021;122:108127. PMID: 34147020. DOI: 10.1016/j.yebeh.2021.108127. http://www.ncbi.nlm.nih.gov/pubmed/34147020
Enlace

Fraguas D, Zarco J, Balanzá-Martínez V, Blázquez García JF, Borràs Murcia C, Cabrera A, Carretero J, Crespo A, Díaz-Marsá M, Gasul V, González MA, Grande I, Muela C, de Las Heras Liñero E, Mayoral F, Morales Cano G, Pagés-Lluyot JR, Romo J, Serrano Marín B, Lozano Sauceda A, Arango C. Humanization in mental health plans in Spain. Rev Psiquiatr Salud Ment. 2021 Sep;(E-PUB) PMID: 34492375. DOI: 10.1016/j.rpsm.2021.08.003. http://www.ncbi.nlm.nih.gov/pubmed/34492375
Enlace

Gómez-Ramiro M, Fico G, Anmella G, Vázquez M, Sagué-Vilavella M, Hidalgo-Mazzei D, Pacchiarotti I, Garriga M, Murru A, Parellada E, Vieta E. Changing trends in psychiatric emergency service admissions during the COVID-19 outbreak: Report from a worldwide epicentre. J Affect Disord. 2021;282:26–32. PMID: 33387743. DOI: 10.1016/j.jad.2020.12.057. http://www.ncbi.nlm.nih.gov/pubmed/33387743
Enlace

Hernández-Rubio L, Asensio-Asensio M, Tortosa-Conesa D, Alfaro-Sáez A, García-Escrivá A, Díaz-Román M, Montoya J, Méndez-Miralles MA, Bertol-Alegre V, Castro-Vilanova MD, Galiano ML, Blanco-Cantó ME, López-González F. [Alzemon: a prospective follow-up study of eslicarbazepine acetate monotherapy in patients with newly diagnosed epilepsy]. Rev Neurol. 2021 Apr;72(8):263–8. PMID: 33851715. DOI: 10.33588/rn.7208.2020593. http://www.ncbi.nlm.nih.gov/pubmed/33851715
Enlace

Juan-García FJ, Ouviña-Arribas R. [Use of ultrasound in decision-making on painful shoulder]. Rehabilitacion. 2021;55(4):329–30. PMID: 33663809. DOI: 10.1016/j.rh.2021.01.004. http://www.ncbi.nlm.nih.gov/pubmed/33663809
Enlace

Lado-Codesido M, Rey Varela RM, Larios Quinones M, Martinez Agulleiro L, OssaBasanes J, Martinez Querol M, Mateos R, Spuch C, Garcia-Caballero A. Voices 2:Improving Prosodic Recognition in Schizophrenia With an Online RehabilitationProgram. Front Psychol. 2021 Dec 24;12:739252. doi: 10.3389/fpsyg.2021.739252.eCollection 2021. PubMed PMID: 35002838; PubMed Central PMCID: PMC8739759.

Madero S, Anmella G, Sague-Vilavella M, Pons MT, Gimenez A, Murru A,Gomez-Ramiro M, Gil-Badenes J, Rios J, Bioque M, Vieta E, Benabarre A. Evaluatingmaintenance electroconvulsive therapy in Bipolar Disorders: 3-year mirror-imagestudy. J Affect Disord. 2022 Feb 1;298(Pt A):58-64. doi:10.1016/j.jad.2021.10.052. Epub 2021 Oct 27. PubMed PMID: 34715196.
Enlace

Meca-Lallana JE, Maurino J, Pérez-Miralles F, Forero L, Sepúlveda M, Calles C, Martínez-Ginés ML, González-Suárez I, Boyero S, Romero-Pinel L, Sempere ÁP, Meca-Lallana V, Querol L, Costa-Frossard L, Prefasi D, Gómez-Ballesteros R, Ballesteros J. Quantifying the patient´s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire. PLoS One. 2021;16(7):e0255317. PMID: 34324586. DOI: 10.1371/journal.pone.0255317. http://www.ncbi.nlm.nih.gov/pubmed/34324586
Enlace

Meca-Lallana JE, Prefasi D, Pérez-Miralles F, Forero L, Sepúlveda M, Calles C, Martínez-Ginés ML, González-Suárez I, Boyero S, Romero-Pinel L, Sempere ÁP, Meca-Lallana V, Querol L, Costa-Frossard L, de Castro-Trapiello H, Canal N, Maurino J. Perception of Stigma in Patients with Neuromyelitis Optica Spectrum Disorder. Patient Prefer Adherence. 2021;15:713–9. PMID: 33880015. DOI: 10.2147/PPA.S305707. http://www.ncbi.nlm.nih.gov/pubmed/33880015
Enlace

Olivares JM, González-Pinto A, Páramo M, PROSIGO Study Group. Predictors of persistence in patients with schizophrenia treated with aripiprazole once-monthly long-acting injection in the Spanish clinical practice: a retrospective, observational study. Eur Psychiatry. 2021 Apr;64(1):e40. PMID: 33840396. DOI: 10.1192/j.eurpsy.2021.23. http://www.ncbi.nlm.nih.gov/pubmed/33840396
Enlace

Palma-Alvarez RF, Ros-Cucurull E, Daigre C, Perea-Ortueta M, Martinez-Luna N,Serrano-Perez P, Sorribes-Puertas M, Ramos-Quiroga JA, Grau-Lopez L, Roncero C.Is alexithymia related to retention and relapses in patients with substance usedisorders?: A one year follow-up study. Addict Behav. 2021 Feb;113:106681. doi:10.1016/j.addbeh.2020.106681. Epub 2020 Oct 1. PubMed PMID: 33038681.

Palma-Alvarez RF, Ros-Cucurull E, Daigre C, Perea-Ortueta M, Serrano-Perez P,Martinez-Luna N, Salas-Martinez A, Robles-Martinez M, Ramos-Quiroga JA, RonceroC, Grau-Lopez L. Alexithymia in Patients With Substance Use Disorders and ItsRelationship With Psychiatric Comorbidities and Health-Related Quality of Life.Front Psychiatry. 2021 Apr 9;12:659063. doi: 10.3389/fpsyt.2021.659063.eCollection 2021. PubMed PMID: 33897505; PubMed Central PMCID: PMC8062860.

Palma-Alvarez RF, Soriano-Dia A, Ros-Cucurull E, Daigre C, Serrano-Perez P,Ortega-Hernandez G, Perea-Ortueta M, Gurrea Salas D, Ramos-Quiroga JA, Grau-LopezL. Catatonia Related to Cannabis and Synthetic Cannabinoids: A Review. J DualDiagn. 2021 Apr-Jun;17(2):159-171. doi: 10.1080/15504263.2021.1904163. Epub 2021Apr 26. PubMed PMID: 33902405.

Penedo MA, Rivera-Baltanás T, Pérez-Rodríguez D, Allen J, Borrajo A, Alonso-Crespo D, Fernández-Pereira C, Nieto-Araujo M, Ramos-García S, Barreiro-Villar C, Caruncho HJ, Olivares JM, Agís-Balboa RC. The role of dopamine receptors in lymphocytes and their changes in schizophrenia. Brain, Behav Immun – Heal. 2021 Mar;12:100199. PMID: 34589732. DOI: 10.1016/j.bbih.2021.100199. http://www.ncbi.nlm.nih.gov/pubmed/34589732
Enlace

Pérez-Rodríguez D, López-Fernández H, Agís-Balboa RC. Application of miRNA-seq in neuropsychiatry: A methodological perspective. Comput Biol Med. 2021 Jun;135:104603. PMID: 34216893. DOI: 10.1016/j.compbiomed.2021.104603. http://www.ncbi.nlm.nih.gov/pubmed/34216893
Enlace

Rodrigues-Amorim D, Iglesias-Martínez-Almeida M, Rivera-Baltanás T, Fernández-Palleiro P, Freiría-Martínez L, Rodríguez-Jamardo C, Comís-Tuche M, Vallejo-Curto MDC, Álvarez-Ariza M, López-García M, de Las Heras E, García-Caballero A, Olivares JM, Spuch C. The Role of the Second Extracellular Loop of Norepinephrine Transporter, Neurotrophin-3 and Tropomyosin Receptor Kinase C in T Cells: A Peripheral Biomarker in the Etiology of Schizophrenia. Int J Mol Sci. 2021 Aug;22(16):8499. PMID: 34445205. DOI: 10.3390/ijms22168499. http://www.ncbi.nlm.nih.gov/pubmed/34445205
Enlace

Rodríguez de Antonio LA, García Castañón I, Aguilar-Amat Prior MJ, Puertas I, González Suárez I, Oreja Guevara C. Non-inflammatory causes of emergency consultation in patients with multiple sclerosis. Neurologia. 2021;36(6):403–11. PMID: 34238522. DOI: 10.1016/j.nrleng.2018.02.005. http://www.ncbi.nlm.nih.gov/pubmed/34238522
Enlace

Rodríguez de Antonio LA, González-Suárez I, Fernández-Barriuso I, Rabasa Pérez M. Para-infectious anti-GD2/GD3 IgM myelitis during the Covid-19 pandemic: Case report and literature review. Mult Scler Relat Disord. 2021 Apr;49:102783. PMID: 33513521. DOI: 10.1016/j.msard.2021.102783. http://www.ncbi.nlm.nih.gov/pubmed/33513521
Enlace

Rodríguez-Osorio X, Lema-Facal T, Rubio-Nazábal E, Castro-Vilanova MD, Pato-Pato A, Abella-Corral J, Corredera E, López-Ferreiro A, Puy-Núñez A, López-González FJ. Perampanel effectiveness and safety as early add-on treatment for focal-onset seizures: PEREAGAL study. Epilepsy Res. 2021;172:106570. PMID: 33621770. DOI: 10.1016/j.eplepsyres.2021.106570. http://www.ncbi.nlm.nih.gov/pubmed/33621770
Enlace

Such P, Olivares JM, Arias L, Troels Berg M, Madera J. Online Survey of Clinical Practice in Patients with Schizophrenia Treated with Long-Acting Injectable Aripiprazole or Paliperidone Palmitate. Neuropsychiatr Dis Treat. 2021;17:1881–92. PMID: 34140772. DOI: 10.2147/NDT.S303292. http://www.ncbi.nlm.nih.gov/pubmed/34140772
Enlace

Torres-Castano A, Rivero-Santana A, Perestelo-Perez L, Duarte-Diaz A,Toledo-Chavarri A, Ramos-Garcia V, Alvarez-Perez Y, Cudeiro-Mazaira J,Padron-Gonzalez I, Serrano-Perez P. Transcranial Magnetic Stimulation for theTreatment of Cocaine Addiction: A Systematic Review. J Clin Med. 2021 Nov28;10(23):5595. doi: 10.3390/jcm10235595. PubMed PMID: 34884297; PubMed CentralPMCID: PMC8658408.

Vaamonde-Lorenzo L, Juan-García FJ. [Rehabilitation physician involvement in teaching biomedical engineering]. Rehabilitacion. 2021;55(4):330–1. PMID: 33846020. DOI: 10.1016/j.rh.2021.03.002. http://www.ncbi.nlm.nih.gov/pubmed/33846020
Enlace

Vallejo-Curto MDC, Rodrigues-Amorim D, Jardón-Golmar L, Blanco-Formoso M, Rivera-Baltanás T, Rodriguez-Jamardo C, Fernández-Palleiro P, Álvarez-Ariza M, López-García M, García-Caballero A, de Las Heras E, Olivares JM, Spuch C. Proteomic and metabolic profiling of chronic patients with schizophrenia induced by a physical activity program: Pilot study. Rev Psiquiatr Salud Ment. 2021 Nov;14(3):125–38. PMID: 34384726. DOI: 10.1016/j.rpsmen.2021.07.002. http://www.ncbi.nlm.nih.gov/pubmed/34384726
Enlace

Vilar-Lopez R, Daugherty JC, Perez-Garcia M, Pinon-Blanco A. A pilot study onthe adequacy of the TOMM in detecting invalid performance in patients withsubstance use disorders. J Clin Exp Neuropsychol. 2021 Apr;43(3):255-263. doi:10.1080/13803395.2021.1912298. Epub 2021 Apr 15. Erratum In: J Clin ExpNeuropsychol. 2021 May 19;:1. PubMed PMID: 33855936.

Spuch C. Capítulo 8. Microbiotica. El Impacto de la Nueva Medicina en el Sistema Sanitario. Fundación Bamberg; 2021. p. 181–248. DL: M-1731-2021. ISBN: 978-84-09-27161-0.

Bartolome F, Krzyzanowska A, de la Cueva M, Pascual C, Antequera D, Spuch C, Villarejo-Galende A, Rabano A, Fortea J, Alcolea D, Lleo A, Ferrer I, Hardy J, Abramov AY, Carro E. Annexin A5 prevents amyloid-?-induced toxicity in choroid plexus: implication for Alzheimer’s disease. Sci Rep. 2020;10(1):9391. PMID: 32523019. DOI: 10.1038/s41598-020-66177-5. http://www.ncbi.nlm.nih.gov/pubmed/32523019
Enlace

Fernández-Palleiro P, Rivera-Baltanás T, Rodrigues-Amorim D, Fernández-Gil S, Del Carmen Vallejo-Curto M, Álvarez-Ariza M, López M, Rodriguez-Jamardo C, Luis Benavente J, de Las Heras E, Manuel Olivares J, Spuch C. Brainwaves Oscillations as a Potential Biomarker for Major Depression Disorder Risk. Clin EEG Neurosci. 2020 Jan;51(1):3–9. PMID: 31537100. DOI: 10.1177/1550059419876807. http://www.ncbi.nlm.nih.gov/pubmed/31537100
Enlace

Garcia-Perez L, Linertova R, Serrano-Perez P, Trujillo-Martin M,Rodriguez-Rodriguez L, Valcarcel-Nazco C, Del Pino-Sedeno T. Interventions toimprove medication adherence in mental health: the update of a systematic reviewof cost-effectiveness. Int J Psychiatry Clin Pract. 2020 Nov;24(4):416-427. doi:10.1080/13651501.2020.1782434. Epub 2020 Jul 1. PubMed PMID: 32609024.

Manzano-Palomo S, Agüera-Ortiz LF, García-Caballero A, Martínez-Raga J, Ojea-Ortega T, Sánchez-Valle R, Antón-Jiménez M, Monge-Argilés JA, Ramos-García I. Use of Antipsychotics in Patients with Behavioral and Psychological Symptoms of Dementia: Results of a Spanish Delphi Consensus. Dement Geriatr Cogn Disord. 2020;49(6):573–82. PMID: 33176326. DOI: 10.1159/000510866. http://www.ncbi.nlm.nih.gov/pubmed/33176326
Enlace

Martínez RÁ, Rodríguez RMT, Ariza MÁ, Spuch C, Olivares JM. Mania as Debut of Cushing’s Syndrome. Case Rep Psychiatry. 2020 Mar;2020:9127632. PMID: 32190397. DOI: 10.1155/2020/9127632. http://www.ncbi.nlm.nih.gov/pubmed/32190397
Enlace

Mercadé Cerdá JM, López Gonzalez FJ, Serrano Castro P, Castro Vilanova MD, Campos Blanco DM, Querol Pascual MR, en representación del Grupo de Estudio de Epilepsia de la SEN. Observational multicentre study into the use of antiepileptic drugs in Spanish neurology consultations. Neurologia. 2020 Mar;35(2):115–25. PMID: 29530436. DOI: 10.1016/j.nrl.2018.01.011. http://www.ncbi.nlm.nih.gov/pubmed/29530436
Enlace

Pinón-Blanco A, Vergara-Moragues E, Fernández-Martínez R, Gutiérrez-Martínez O, Alvarez-Counago M, Martínez-Reglero C, Rivera-Baltanás T, Otero-Lamas F, Olivares-Diez J, Spuch-Calvar C. Effectiveness of the “Trisquel” board game intervention program for patients with schizophrenia spectrum disorders. Actas Esp Psiquiatr. 2020;48(5):209–19. PMID: 33210279. http://www.ncbi.nlm.nih.gov/pubmed/33210279
Enlace

Rodrigues-Amorim D, Olivares JM, Spuch C, Rivera-Baltanás T. A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine. Front psychiatry. 2020;11:554899. PMID: 33192668. DOI: 10.3389/fpsyt.2020.554899. http://www.ncbi.nlm.nih.gov/pubmed/33192668
Enlace

Rodrigues-Amorim D, Rivera-Baltanás T, Del Carmen Vallejo-Curto M, Rodriguez-Jamardo C, de Las Heras E, Barreiro-Villar C, Blanco-Formoso M, Fernández-Palleiro P, Álvarez-Ariza M, López M, García-Caballero A, Olivares JM, Spuch C. Plasma Beta-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia. Sci Rep. 2020;10(1):14271. PMID: 32868793. DOI: 10.1038/s41598-020-71060-4. http://www.ncbi.nlm.nih.gov/pubmed/32868793
Enlace

Spuch C, López-García M, Rivera-Baltanás T, Rodrígues-Amorím D, Olivares JM. Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report. Front Pharmacol. 2020 Aug;11:557629. PMID: 32973537. DOI: 10.3389/fphar.2020.557629. http://www.ncbi.nlm.nih.gov/pubmed/32973537
Enlace

Tejada Meza H, Lambea Gil Á, Sancho Saldaña A, Martínez-Zabaleta M, Garmendia Lopetegui E, López-Cancio Martínez E, Castañón Apilánez M, Herrera Isasi M, Marta Enguita J, Gómez-Vicente B, Arenillas JF, Arenaza Basterrechea N, Timiraos Fernández JJ, Sánchez Herrero J, Maciñeiras Montero JL, Castellanos Rodrigo M, Fernández-Coud D, Casado Menéndez I, Temprano Fernández MT, Freijo M, Luna A, Palacio Portilla EJ, Jiménez López Y, Rodríguez-Castro E, Rodríguez-Yáñez M, Tejada García J, Beltrán Rodríguez I, Julián-Villaverde F, Moreno García MP, Trejo Gabriel-Galán JM, Echavarría Iñiguez A, Pérez Lázaro C, Navarro Pérez MP, Marta Moreno J, NORDICTUS Investigators. Impact of COVID-19 outbreak in reperfusion therapies of acute ischaemic stroke in northwest Spain. Eur J Neurol. 2020;27(12):2491–8. PMID: 32761981. DOI: 10.1111/ene.14467. http://www.ncbi.nlm.nih.gov/pubmed/32761981
Enlace

Toledano Delgado R, García-Morales I, Parejo-Carbonell B, Jiménez-Huete A, Herrera-Ramirez D, González-Hernández A, Ayuga Loro F, Santamarina E, Toledo M, Ojeda J, Poza JJ, Molins A, Giner P, Estévez María JC, Castro-Vilanova MD, Zurita J, Saiz-Diaz RA, Gómez-Ibañez A, Rodriguez-Uranga J, Gil-Nagel A, Campos D, Sánchez-Larsen Á, Aguilar-Amat Prior MJ, Mauri Llerda JA, Huertas González N, García-Barragán N. Effectiveness and safety of perampanel monotherapy for focal and generalized tonic-clonic seizures: Experience from a national multicenter registry. Epilepsia. 2020;61(6):1109–19. PMID: 32511754. DOI: 10.1111/epi.16548. http://www.ncbi.nlm.nih.gov/pubmed/32511754
Enlace

Álvarez Martínez R, Tomé Rodríguez RM, Álvarez Ariza M, Spuch C, Olivares JM. Mania as Debut of Cushing’s Syndrome. In: Borregón Rivilla M (ed.). Case Reports For Medical Practitioners. Hyderabad, India: Vide Leaf; 2020. p. 1–7. ISBN: 978-93-90014-16-3. https://videleaf.com/mania-as-debut-of-cushings-syndrome-a-case-report/
Enlace

Spuch C, López-García M, Rivera-Baltanás T, Rodrígues-Amorím D, Olivares JM. Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report. In: Borregón Rivilla M (ed.). Case Reports For Medical Practitioners. Hyderabad, India: Vide Leaf; 2020. p. 1–18. ISBN: 978-93-90014-16-3. https://videleaf.com/does-lithium-deserve-a-place-in-the-treatment-against-covid-19-a-preliminary-observational-study-in-six-patients-case-report/
Enlace

Zarco J, Arango C, Crespo A, De las Heras E, Mayoral F, Grande I, Romo J, Carretero J, Díaz M, González MA, Balanzá V, Gasull V. Humanización en Salud Mental. Zarco J, Arango C (eds.). Fundación HUMANS; 2020. DL: M-1958-2020. ISBN: 9788417372958. http://www.fundacionhumans.com/wp-content/uploads/2020/02/informe-humanizacion-en-salud-mental.pdf
Enlace

Arango C, Baeza I, Bernardo M, Cañas F, de Dios C, Díaz-Marsá M, García-Portilla MP, Gutiérrez-Rojas L, Olivares JM, Rico-Villademoros F, Rodríguez-Jiménez R, Sánchez-Morla EM, Segarra R, Crespo-Facorro B. Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain. Rev Psiquiatr Salud Ment. 2019 Jun;12(2):92–105. PMID: 29954707. DOI: 10.1016/j.rpsm.2018.03.006. http://www.ncbi.nlm.nih.gov/pubmed/29954707
Enlace

Caruncho HJ, Kalynchuk LE, Loza MI, Olivares JM. Editorial: Novel Approaches to the Neuropharmacology of Mood Disorders. Front Pharmacol. 2019;10(MAY):589. PMID: 31156442. DOI: 10.3389/fphar.2019.00589. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533613/pdf/fphar-10-00589.pdf
Enlace

Caruncho HJ, Rivera-Baltanas T, Romay-Tallon R, Kalynchuk LE, Olivares JM. Patterns of Membrane Protein Clustering in Peripheral Lymphocytes as Predictors of Therapeutic Outcomes in Major Depressive Disorder. Front Pharmacol. 2019;10(March):190. PMID: 30930773. DOI: 10.3389/fphar.2019.00190. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423346/pdf/fphar-10-00190.pdf
Enlace

Dieguez-Varela C, Lion-Vazquez S, Fraga-Bau A, Rodriguez-Acevedo B, Rodriguez-Sanchez L, Collazo-Dieguez M, Pereira-Martinez MN, Salgado-Barreira A, Alvarez-Rodriguez E, Vicente-Alba P, Munoz D, Fernandez JM, Ribeiro SJ, Midaglia L. [Intermittent theta-burst transcranial magnetic stimulation for the treatment of spasticity in patients with recurring multiple sclerosis: the results of a double-blind randomised clinical trial]. Rev Neurol. 2019 Jul;69(2):45–52. PMID: 31287147. DOI: 10.33588/rn.6902.2018275. http://www.ncbi.nlm.nih.gov/pubmed/31287147
Enlace

Gallastegui C, Fernández-Vega H, Piñeiro G, Rey-Gómez-Serranillos I, Olivares JM, De Las Heras-Liñero E. Evaluación de la adherencia al tratamiento con antipsicóticos inyectables de liberación prolongada dentro de un programa de seguimiento farmacoterapéutico. Farm Hosp. 2019;43(6):177–81. PMID: 31705640. DOI: 10.7399/fh.11188. http://www.aulamedica.es/fh/pdf/11188.pdf
Enlace

Lado-Codesido M, Méndez Pérez C, Mateos R, Olivares JM, García Caballero A. Improving emotion recognition in schizophrenia with “VOICES”: An on-line prosodic self-training. PLoS One. 2019;14(1):e0210816. PMID: 30682067. DOI: 10.1371/journal.pone.0210816. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347191/pdf/pone.0210816.pdf
Enlace

Piñon Blanco A, Lage López M, Carrera Machado I, Vázquez González M, Cerqueiro Costa X, Bobadilla Pérez V, Spuch Calvar C, Otero Lamas F. Perfil neuropsicológico y sintomatología psicopatológica de pacientes con trastornos relacionados con sustancias a tratamiento en una unidad de día. Heal Addict y Drog. 2019 Feb;19(1):70–9. DOI: 10.21134/haaj.v19i1.412. https://ojsnuevo.haaj.org/index.php/haaj/article/view/412
Enlace

Piñón-Blanco A, Carballido E, Vázquez E, Fernandes S, Gutiérrez O, Spuch C. Rendimiento neuropsicológico de niños y niñas con Trastorno por Déficit de Atención e Hiperactividad (TDAH). Cuad Neuropsicol / Panam J Neuropsychol. 2019 Jan;13(1):116–32. DOI: 10.7714/CNPS/13.1.206. https://dialnet.unirioja.es/servlet/articulo?codigo=6934930#
Enlace

Rodrigues-Amorim D, Rivera-Baltanás T, Vallejo-Curto M del C, Rodriguez-Jamardo C, de Las Heras E, Barreiro-Villar C, Blanco-Formoso M, Fernández-Palleiro P, Álvarez-Ariza M, López M, García-Caballero A, Olivares JM, Spuch C. Proteomics in Schizophrenia: A Gateway to Discover Potential Biomarkers of Psychoneuroimmune Pathways. Front psychiatry. 2019;10(November):885. PMID: 31849731. DOI: 10.3389/fpsyt.2019.00885. http://www.ncbi.nlm.nih.gov/pubmed/31849731
Enlace

Salagre E, Arango C, Artigas F, Ayuso-Mateos JL, Bernardo M, Castro-Fornieles J, Bobes J, Desco M, Fañanás L, González-Pinto A, Haro JM, Leza JC, Mckenna PJ, Meana JJ, Menchón JM, Micó JA, Palomo T, Pazos Á, Pérez V, Saiz-Ruiz J, Sanjuán J, Tabarés-Seisdedos R, Crespo-Facorro B, Casas M, Vilella E, Palao D, Olivares JM, Rodriguez-Jimenez R, Vieta E. CIBERSAM: Ten years of collaborative translational research in mental disorders. Rev Psiquiatr Salud Ment. 2019 Jan;12(1):1–8. PMID: 30416047. DOI: 10.1016/j.rpsm.2018.10.001. http://www.ncbi.nlm.nih.gov/pubmed/30416047
Enlace

Sánchez-Reales S, Caballero-Peláez C, Prado-Abril J, Inchausti F, Lado-Codesido M, García-Caballero A, Lahera G. Spanish validation of the “Reading the Mind in the Voice” task: A study of complex emotion recognition in adults with autism spectrum conditions. Res Autism Spectr Disord. 2019 Nov;67:101421. DOI: 10.1016/j.rasd.2019.101421. http://doi.org/10.1016/j.rasd.2019.101421
Enlace

Toledo M, Mazuela G, Mauri JA, Rodriguez-Osorio X, Gómez-Eguilaz M, Castro-Vilanova D, Rodriguez-Uranga J, Santamarina E. Levels of anger in epilepsy patients treated with eslicarbazepine acetate. Acta Neurol Scand. 2019 Jul;140(1):48–55. PMID: 30953593. DOI: 10.1111/ane.13099. http://www.ncbi.nlm.nih.gov/pubmed/30953593
Enlace

Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, Sabers A, Thomas S V, Vajda F, EURAP Study Group (MD Castro-Vilanova). Declining malformation rates with changed antiepileptic drug prescribing: An observational study. Neurology. 2019;93(9):e831–40. PMID: 31391249. DOI: 10.1212/WNL.0000000000008001. http://www.ncbi.nlm.nih.gov/pubmed/31391249
Enlace

Villanueva V, Bermejo P, Montoya J, Massot-Tarrús A, Galiano ML, Toledo M, Rodriguez-Uranga JJ, Bertol V, Mauri JÁ, Poza JJ, Bonet M, Castro-Vilanova MD, Ruiz-Giménez J, López-González FJ, Rodríguez-Osorio X, Tortosa-Conesa D, Ojeda J, Giner P, Garcés M, Alvarez BM, Quiroga-Subirana P, Esteve P, Baiges JJ, Hampel K. MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy. Epilepsy Behav. 2019;97:51–9. PMID: 31181429. DOI: 10.1016/j.yebeh.2019.05.003. http://www.ncbi.nlm.nih.gov/pubmed/31181429
Enlace

Villanueva V, López-González FJ, Mauri JA, Rodriguez-Uranga J, Olivé-Gadea M, Montoya J, Ruiz-Giménez J, Zurita J, BRIVA-LIFE study group (MD Castro-Vilanova). BRIVA-LIFE-A multicenter retrospective study of the long-term use of brivaracetam in clinical practice. Acta Neurol Scand. 2019 Apr;139(4):360–8. PMID: 30506559. DOI: 10.1111/ane.13059. http://www.ncbi.nlm.nih.gov/pubmed/30506559
Enlace

Alcaraz S, González-Saiz F, Trujols J, Vergara-Moragues E, Siñol N, Pérez de Los Cobos J, Buprenorphine Naloxone Survey Group (Manuel Conde). A cluster-analytic profiling of heroin-dependent patients based on level, clinical adequacy, and patient-desired adjustment of buprenorphine dosage during buprenorphine-naloxone maintenance treatment in sixteen Spanish centers. Drug Alcohol Depend. 2018;187:278–84. PMID: 29702336. DOI: 10.1016/j.drugalcdep.2018.02.020. http://www.ncbi.nlm.nih.gov/pubmed/29702336
Enlace

Fernández M, Lago L, Alonso MG, Guede A, Benavente JL, Olivares JM. Serotonin syndrome versus neuroleptic malignant syndrome: a case report. Actas españolas Psiquiatr. 2018 Mar;46(2):68–74. PMID: 29616715. http://www.ncbi.nlm.nih.gov/pubmed/29616715
Enlace

Formigo J, Juan-Garcia FJ. Utilidad de la punción-aspiración con aguja fina ecoguiada, tras la aplicación de ondas de choque extracorpóreas en la tendinitis del manguito de los rotadores. Espac Dolor. 2018;1(1):23–5.

García-Caballero TM, Lojo J, Menéndez C, Fernández-Álvarez R, Mateos R, Garcia-Caballero A. Polimedication: applicability of a computer tool to reduce polypharmacy in nursing homes. Int psychogeriatrics. 2018 Jul;30(7):1001–8. PMID: 29747709. DOI: 10.1017/S1041610217002411. http://www.ncbi.nlm.nih.gov/pubmed/29747709
Enlace

González-Saiz F, Lozano Rojas O, Trujols J, Alcaraz S, Siñol N, Pérez de Los Cobos J, Buprenorphine Naloxone Survey Group (Manuel Conde). Evidence of validity and reliability of the Opiate Dosage Adequacy Scale (ODAS) in a sample of heroin addicted patients in buprenorphine/naloxone maintenance treatment. Drug Alcohol Depend. 2018;183:127–33. PMID: 29247974. DOI: 10.1016/j.drugalcdep.2017.10.035. http://www.ncbi.nlm.nih.gov/pubmed/29247974
Enlace

Maroño Souto Y, Vázquez Campo M, Díaz Llenderrozas F, Rodríguez Álvarez M, Mateos R, García Caballero A. Randomized Clinical Trial with e-MotionalTraining® 1.0 for Social Cognition Rehabilitation in Schizophrenia. Front psychiatry. 2018;9(FEB):40. PMID: 29535646. DOI: 10.3389/fpsyt.2018.00040. http://www.ncbi.nlm.nih.gov/pubmed/29535646
Enlace

Muñoz-Lopetegi A, López-González FJ, Rodríguez-Osorio X, Pato Pato A, Bellas Lamas P, Abella-Corral J, Castro Vilanova MD, Garea MJ, Gil López JA, Ruiz-Martínez J, Poza JJ. LACONORTE study: Efficacy and security of lacosamide as first add-on therapy for focal-onset epilepsy in real-life setting. Epilepsy Res. 2018;145:51–4. PMID: 29890341. DOI: 10.1016/j.eplepsyres.2018.05.011. http://www.ncbi.nlm.nih.gov/pubmed/29890341
Enlace

Piñón Blanco A, Vergara Moragues E, Torres Rincón T, Gutiérrez Martínez O, Conde Amado M, Vázquez Justo E, Otero Lamas F. Diferencias entre hombres y mujeres en los procesos de toma de decisiones en pacientes con trastornos relacionados con sustancias. Rev Latinoam Psicol. 2018 Dec;50(1):160–9. DOI: 10.14349/rlp.2018.v50.n3.3. http://dx.doi.org/10.14349/rlp.2018.v50.n3.3
Enlace

Piñón-Blanco A, Álvarez MC, Torres-Rincón TM, Vázquez P, Otero F. Neuropsychological profile of patients diagnosed with schizophrenia spectrum disorder. Rev Discapacidad, Clínica y Neurociencias. 2018;5(1):1–04. https://dialnet.unirioja.es/servlet/articulo?codigo=6312752
Enlace

Rodrigues-Amorim D, Rivera-Baltanás T, Bessa J, Sousa N, Vallejo-Curto M de C, Rodríguez-Jamardo C, de Las Heras ME, Díaz R, Agís-Balboa RC, Olivares JM, Spuch C. The neurobiological hypothesis of neurotrophins in the pathophysiology of schizophrenia: A meta-analysis. J Psychiatr Res. 2018;106:43–53. PMID: 30269004. DOI: 10.1016/j.jpsychires.2018.09.007. http://www.ncbi.nlm.nih.gov/pubmed/30269004
Enlace

Rodrigues-Amorim D, Rivera-Baltanás T, Regueiro B, Spuch C, de Las Heras ME, Vázquez-Noguerol Méndez R, Nieto-Araujo M, Barreiro-Villar C, Olivares JM, Agís-Balboa RC. The role of the gut microbiota in schizophrenia: Current and future perspectives. World J Biol Psychiatry. 2018 Feb;19(8):571–85. PMID: 29383983. DOI: 10.1080/15622975.2018.1433878. http://www.ncbi.nlm.nih.gov/pubmed/29383983
Enlace

Rodrigues-Amorim D, Rivera-Baltanás T, Spuch C, Caruncho HJ, González-Fernandez Á, Olivares JM, Agís-Balboa RC. Cytokines dysregulation in schizophrenia: A systematic review of psychoneuroimmune relationship. Schizophr Res. 2018 Nov;197:19–33. PMID: 29239785. DOI: 10.1016/j.schres.2017.11.023. http://www.ncbi.nlm.nih.gov/pubmed/29239785
Enlace

Romay-Tallon R, Kulhawy E, Brymer KJ, Allen J, Rivera-Baltanas T, Olivares JM, Kalynchuk LE, Caruncho HJ. Changes in Membrane Protein Clustering in Peripheral Lymphocytes in an Animal Model of Depression Parallel Those Observed in Naïve Depression Patients: Implications for the Development of Novel Biomarkers of Depression. Front Pharmacol. 2018;9:1149. PMID: 30374301. DOI: 10.3389/fphar.2018.01149. http://www.ncbi.nlm.nih.gov/pubmed/30374301
Enlace

Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, Sabers A, Thomas S V, Vajda F, EURAP Study Group (MD Castro-Vilanova). Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol. 2018;17(6):530–8. PMID: 29680205. DOI: 10.1016/S1474-4422(18)30107-8. http://www.ncbi.nlm.nih.gov/pubmed/29680205
Enlace

Torres-Rincón TM, Pinion-Blanco A, Vázquez-Justo, Otero-Lamas. Neuropsychological alterations in borderline personality disorder: purpose of a case. J Psychol Clin Psychiatry. 2018 Nov;9(6):683–7. DOI: 10.15406/jpcpy.2018.09.00611. https://medcraveonline.com/JPCPY/JPCPY-09-00611
Enlace

Vicente-Alba P, Moreno-Carretero MJ, San Millan-Tejado B, Outomuro-Perez JM. [Behavioural variant of frontotemporal dementia as the presenting symptom of corticobasal degeneration]. Rev Neurol. 2018 Dec;67(11):436–40. PMID: 30484276. http://www.ncbi.nlm.nih.gov/pubmed/30484276
Enlace

Zapata-Wainberg G, Quintas S, Ximénez-Carrillo Rico Á, Masjuán Vallejo J, Cardona P, Castellanos Rodrigo M, Benavente Fernández L, García Pastor A, Egido J, Maciñeiras J, Serena J, Freijo Guerrero M del M, Moniche F, Vivancos J. Epidemiology of Intracranial Hemorrhage Associated with Oral Anticoagulants in Spain: Trends in Anticoagulation Complications Registry – The TAC 2 Study. Interv Neurol. 2018 Apr;7(5):284–95. PMID: 29765398. DOI: 10.1159/000487518. http://www.ncbi.nlm.nih.gov/pubmed/29765398
Enlace

Formigo-Couceiro J, Juan-García FJ, Barrio-Alonso M. Técnicas intervencionistas en el paciente con secuelas neurológicas: bloqueos de nervios periféricos en la espasticidad. Notas de Neurorrehabilitación. A Coruña: Editorial Seteis Comunicación Creatividade SL; 2018. p. 77–82. DL: C-1929-2018. ISBN: 978-84-09-06075-7.

Formigo-Couceiro J, Juan-García FJ, editors. Técnicas básicas de rehabilitación intervencionista ecoguiadas. SOGARMEF. Enfoque Editorial S.C; 2018. DL: M-31006-2018. ISBN: 978-84-16813-90-2. https://www.sogarmef.org/project/libro-tecnicas-basicas-de-rehabilitacion-intervencionista-ecoguiadas/
Enlace

Formigo-Couceiro J, Juan-García FJ, editors. Técnicas básicas de rehabilitación intervencionista ecoguiadas. SOGARMEF. Enfoque Editorial S.C; 2018. DL: M-31006-2018. ISBN: 978-84-16813-90-2. https://www.sogarmef.org/project/libro-tecnicas-basicas-de-rehabilitacion-intervencionista-ecoguiadas/
Enlace

Grupo de trabajo del proyecto Biblioterapia Lecturas Saludables (María Álvarez Ariza; Elena de las Heras). Biblioterapia. Lecturas saludables. Consellería de Sanidade-Servicio Galego de Saúde, Axencia Galega para a Xestión do Coñecemento en Saúde (ACIS), Unidad de Asesoramiento científico-técnico. Avalia-t (eds.). Santiago de Compostela: Xunta de Galicia; 2018. DL: C 92-2019. https://bibliosaude.sergas.gal/DXerais/928/BIBLIOTERAPIA_lecturas saludables_ES.pdf
Enlace

Grupo de trabajo del proyecto Biblioterapia Lecturas Saludables (María Álvarez Ariza; Elena de las Heras). Biblioterapia. Lecturas saludables. Guía de libros recomendados. Consellería de Sanidade-Servicio Galego de Saude; Agencia Gallega para la Gestión del Conocimiento en Salud (ACIS); Unidad de Asesoramiento científico-técnico. Avalia-t (ed.). Santiago de Compostela: Xunta de Galicia; 2018. DL: C 93-2019. https://bibliosaude.sergas.gal/DXerais/928/GUÍA LIBROS RECOMENDADOS_ES.pdf
Enlace

Juan-García FJ, editor. Notas de Neurorrehabilitación. A Coruña: Editorial Seteis Comunicación Creatividade SL; 2018. DL: C-1929-2018. ISBN: 978-84-09-06075-7.

Juan-Garcia FJ. Cuidados y evaluaciones periódicas en pacientes con lesión medular tras el alta de la fase aguda. Notas de Neurorrehabilitación. A Coruña: Editorial Seteis Comunicación Creatividade SL; 2018. p. 44–54. DL: C-1929-2018. ISBN: 978-84-09-06075-7.

Juan-García FJ. Espasticidad en la Esclerosis Múltiple. Notas de Neurorrehabilitación. A Coruña: Editorial Seteis Comunicación Creatividade SL; 2018. p. 64–72. DL: C-1929-2018. ISBN: 978-84-09-06075-7.

Juan-García, Francisco Javier; Barrio-Alonso, Manuela; Formigo-Couceiro, Jacobo, editors. Bloqueos básicos en el paciente espástico. SOGARMEF. Enfoque Editorial S.C; 2018. DL: M-31006-2018. ISBN: 978-84-16813-90-2. https://www.sogarmef.org/project/libro-tecnicas-basicas-de-rehabilitacion-intervencionista-ecoguiadas/
Enlace

Reboiro-Jato M, López-Fernández H, Laza-Fidalgo R, Pavón-Rial MR, Rojas-Rodríguez F, Vieira-Vázquez A, Rivera-Baltanás T, Spuch-Calvar C, Varela-Pomar A, Otero-Lamas F, Piñón-Blanco A. MultiTasking Cubes: unha ferramenta para a rehabilitacion cognitiva. In: De-Blas-Varela E, Rodríguez-Vázquez V, Vila-Sobrino XA, Álvarez-González S (eds.). Proxectos INOU 2017 Investigación aplicada na provincia de Ourense. Universidade de Vigo; 2018. p. 63–77. DL: VG 665-2018. ISBN: 978-84-8158-800-2. https://dialnet.unirioja.es/servlet/articulo?codigo=6691641
Enlace

Alvarez-Ariza M, Alvarez Garcia C, Atienza-Merino G, Basanta Matos R, Goicoechea-Castaño A, De-las-Heras-Liñero E, Mazaira Castro J, Montiel Carracedo D, Paz Valiñas L, Tajes Alonso M, Triñanes Pego Y, Varela Reboiras L, Grupo de trabajo de la actualización de la Guía de Práctica Clínica sobre la Depresión Mayor en la Infancia y Adolescencia. Guía de Práctica Clínica sobre la Depresión Mayor en la Infancia y Adolescencia. Actualización. Guía Rápida. Ministerio de Sanidad Servicios Sociales e Igualdad, Unidad de Asesoramiento Científico-técnico. Avalía-t (eds.). 2018. Guías de Práctica Clínica en el SNS. DL: C 152-201. https://portal.guiasalud.es/gpc/depresion-infancia/
Enlace

Agís-Balboa RC, Pinheiro PS, Rebola N, Kerimoglu C, Benito E, Gertig M, Bahari-Javan S, Jain G, Burkhardt S, Delalle I, Jatzko A, Dettenhofer M, Zunszain PA, Schmitt A, Falkai P, Pape JC, Binder EB, Mulle C, Fischer A, Sananbenesi F. Formin 2 links neuropsychiatric phenotypes at young age to an increased risk for dementia. EMBO J. 2017 Oct;36(19):2815–28. PMID: 28768717. DOI: 10.15252/embj.201796821. IF2017: 10.557; D1. http://www.ncbi.nlm.nih.gov/pubmed/28768717
Enlace

Álvarez-Payero M, Valeiras-Muñoz C, Lion-Vázquez S, Piñeiro-Corrales G, Muñoz-García D, Midaglia L. Experience with fampridine in clinical practice: analysis of a possible marker of clinical response. Int J Neurosci. 2017 Oct;127(10):915–22. PMID: 28054826. DOI: 10.1080/00207454.2017.1279614. IF2017: 1.848; Q4. http://www.ncbi.nlm.nih.gov/pubmed/28054826
Enlace

Amado A, Blanco MO, Repáraz-Andrade A. Spinocerebellar Ataxia 27: Clinical Phenotype of Twin Sisters with FGF14 Deletion. Neuropediatrics. 2017 Feb;48(2):131. PMID: 28192817. DOI: 10.1055/s-0037-1598110. IF2017: 1.605; Q3. http://www.ncbi.nlm.nih.gov/pubmed/28192817
Enlace

Cabrerizo M, García-Iñiguez JP, Munell F, Amado A, Madurga-Revilla P, Rodrigo C, Pérez S, Martínez-Sapiña A, Antón A, Suárez G, Rabella N, Del Campo V, Otero A, Masa-Calles J. First Cases of Severe Flaccid Paralysis Associated With Enterovirus D68 Infection in Spain, 2015-2016. Pediatr Infect Dis J. 2017 Dec;36(12):1214–6. PMID: 28661963. DOI: 10.1097/INF.0000000000001668. IF2017: 2.305; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28661963
Enlace

Crespo-Facorro B, Bernardo M, Argimon JM, Arrojo M, Bravo-Ortiz MF, Cabrera-Cifuentes A, Carretero-Román J, Franco-Martín MA, García-Portilla P, Haro JM, Olivares JM, Penadés R, Del Pino-Montes J, Sanjuán J, Arango C. Effectiveness, efficiency and efficacy in the multidimensional treatment of schizophrenia: Rethinking project. Rev Psiquiatr Salud Ment. 2017 Jan;10(1):4–20. PMID: 27777062. DOI: 10.1016/j.rpsm.2016.09.001. IF2017: 2.233; Q2. http://www.ncbi.nlm.nih.gov/pubmed/27777062
Enlace

Cuadrado ML, Aledo-Serrano Á, Navarro P, López-Ruiz P, Fernández-de-Las-Peñas C, González-Suárez I, Orviz A, Fernández-Pérez C. Short-term effects of greater occipital nerve blocks in chronic migraine: A double-blind, randomised, placebo-controlled clinical trial. Cephalalgia. 2017 Aug;37(9):864–72. PMID: 27296456. DOI: 10.1177/0333102416655159. IF2017: 3.886; Q1. http://www.ncbi.nlm.nih.gov/pubmed/27296456
Enlace

Delgado-Morales R, Agís-Balboa RC, Esteller M, Berdasco M. Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders. Clin Epigenetics. 2017 Dec;9(1):67. PMID: 28670349. DOI: 10.1186/s13148-017-0365-z. IF2017: 6.091; Q1. http://www.ncbi.nlm.nih.gov/pubmed/28670349
Enlace

Fernandez O, Oterino A, Oreja-Guevara C, Prieto JM, Mendibe-Bilbao MM, Garcia-Merino JA, Ramio-Torrenta L, Ginestal R, Meca-Lallana JE, Romero-Pinel L, Munoz D, Oliva-Nacarino P, Calles-Hernandez MC, Izquierdo G, Martinez-Gines ML, Saiz A, Comabella M, Casanova-Estruch B, Brieva L, Arroyo R, Rodriguez-Antiguedad A. Review of the novelties from the 32nd ECTRIMS Congress, 2016, presented at the 9th Post-ECTRIMS Meeting (I). Rev Neurol. 2017 Jul;65(1):31–40. PMID: 28650065. IF2017: 0.601; Q4. http://www.ncbi.nlm.nih.gov/pubmed/28650065
Enlace

Fernandez O, Oterino A, Oreja-Guevara C, Prieto JM, Mendibe-Bilbao MM, Garcia-Merino JA, Ramio-Torrenta L, Ginestal R, Meca-Lallana JE, Romero-Pinel L, Munoz D, Oliva-Nacarino P, Calles-Hernandez MC, Izquierdo G, Martinez-Gines ML, Saiz A, Comabella M, Casanova-Estruch B, Brieva L, Arroyo R, Rodriguez-Antiguedad A. Review of the novelties from the 32nd ECTRIMS Congress, 2016, presented at the 9th Post-ECTRIMS Meeting (II). Rev Neurol. 2017 Jul;65(2):75–84. PMID: 28675259. IF2017: 0.601; Q4. http://www.ncbi.nlm.nih.gov/pubmed/28675259
Enlace

Fuku N, Díaz-Peña R, Arai Y, Abe Y, Zempo H, Naito H, Murakami H, Miyachi M, Spuch C, Serra-Rexach JA, Emanuele E, Hirose N, Lucia A. Epistasis, physical capacity-related genes and exceptional longevity: FNDC5 gene interactions with candidate genes FOXOA3 and APOE. BMC Genomics. 2017 Nov;18(Suppl 8):803. PMID: 29143599. DOI: 10.1186/s12864-017-4194-4. IF2017: 3.730; Q1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688477/pdf/12864_2017_Article_4194.pdf
Enlace

González-Suárez I, Ríos-Blanco JJ, Arpa J. Accelerated atherosclerosis in ANCA-associated vasculitis. Acta Neurol Scand. 2017 Dec;136(6):688–93. PMID: 28608454. DOI: 10.1111/ane.12787. IF2017: 3.126; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28608454
Enlace

González-Suarez I, Rodríguez de Antonio L, Orviz A, Moreno-García S, Valle-Arcos MD, Matias-Guiu JA, Valencia C, Jorquera Moya M, Oreja-Guevara C. Catastrophic outcome of patients with a rebound after Natalizumab treatment discontinuation. Brain Behav. 2017 Apr;7(4):e00671. PMID: 28413713. DOI: 10.1002/brb3.671. IF2017: 2.219; Q3. http://www.ncbi.nlm.nih.gov/pubmed/28413713
Enlace

Kerimoglu C, Sakib MS, Jain G, Benito E, Burkhardt S, Capece V, Kaurani L, Halder R, Agís-Balboa RC, Stilling R, Urbanke H, Kranz A, Stewart AF, Fischer A. KMT2A and KMT2B Mediate Memory Function by Affecting Distinct Genomic Regions. Cell Rep. 2017 Jul;20(3):538–48. PMID: 28723559. DOI: 10.1016/j.celrep.2017.06.072. IF2017: 8.032; D1. http://www.ncbi.nlm.nih.gov/pubmed/28723559
Enlace

Oreja-Guevara C, Gómez-Pinedo U, García-López J, Sánchez-Sánchez R, Valverde-Moyano R, Rabano-Gutierrez A, Matías-Guiu JA, González-Suárez I, Matías-Guiu J. Inhibition of neurogenesis in a case of Marburg variant multiple sclerosis. Mult Scler Relat Disord. 2017 Nov;18:71–6. PMID: 29141824. DOI: 10.1016/j.msard.2017.09.024. IF2017: 3.199; Q2. http://www.ncbi.nlm.nih.gov/pubmed/29141824
Enlace

Pérez V, Salavert A, Espadaler J, Tuson M, Saiz-Ruiz J, Sáez-Navarro C, Bobes J, Baca-García E, Vieta E, Olivares JM, Rodriguez-Jimenez R, Villagrán JM, Gascón J, Cañete-Crespillo J, Solé M, Saiz PA, Ibáñez Á, de Diego-Adeliño J, AB-GEN Collaborative Group, Menchón JM. Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial. BMC Psychiatry. 2017 Dec;17(1):250. PMID: 28705252. DOI: 10.1186/s12888-017-1412-1. IF2017: 2.419; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28705252
Enlace

Petzold A, Balcer LJ, Calabresi PA, Costello F, Frohman TC, Frohman EM, Martinez-Lapiscina EH, Green AJ, Kardon R, Outteryck O, Paul F, Schippling S, Vermersch P, Villoslada P, Balk LJ, ERN-EYE IMSVISUAL. Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol. 2017;16(10):797–812. PMID: 28920886. DOI: 10.1016/S1474-4422(17)30278-8. http://www.ncbi.nlm.nih.gov/pubmed/28920886
Enlace

Rivas L, Blanco Ó, Torreira C, Repáraz A, Melcón C, Amado A. [Pontocerebellar hypoplasia secondary to CASK gene deletion: Case report]. Rev Chil Pediatr. 2017;88(4):529–33. PMID: 28898323. DOI: 10.4067/S0370-41062017000400014. IF2017: N/A. http://www.ncbi.nlm.nih.gov/pubmed/28898323
Enlace

Rodrigues-Amorim D, Rivera-Baltanás T, López M, Spuch C, Olivares JM, Agís-Balboa RC. Schizophrenia: A review of potential biomarkers. J Psychiatr Res. 2017 Oct;93:37–49. PMID: 28578207. DOI: 10.1016/j.jpsychires.2017.05.009. IF2017: 4.000; Q1. http://www.ncbi.nlm.nih.gov/pubmed/28578207
Enlace

Romay-Tallon R, Rivera-Baltanas T, Allen J, Olivares JM, Kalynchuk LE, Caruncho HJ. Comparative study of two protocols for quantitative image-analysis of serotonin transporter clustering in lymphocytes, a putative biomarker of therapeutic efficacy in major depression. Biomark Res. 2017 Dec;5(1):27. PMID: 29018523. DOI: 10.1186/s40364-017-0107-6. IF2017: N/A. http://www.ncbi.nlm.nih.gov/pubmed/29018523
Enlace

Tomas-Roig J, Benito E, Agis-Balboa RC, Piscitelli F, Hoyer-Fender S, Di Marzo V, Havemann-Reinecke U. Chronic exposure to cannabinoids during adolescence causes long-lasting behavioral deficits in adult mice. Addict Biol. 2017 Nov;22(6):1778–89. PMID: 27578457. DOI: 10.1111/adb.12446. IF2017: 5.578; D1. http://www.ncbi.nlm.nih.gov/pubmed/27578457
Enlace

Vázquez Campo M, Diéguez Álvarez J, García-Caballero A. Sesgo “salto a las conclusiones” en pacientes con patología psiquiátrica. Metas de enfermería. 2017;20(6):67–73. IF2017: N/A. https://dialnet.unirioja.es/servlet/articulo?codigo=6082127
Enlace

Álvarez-Ariza M, Goicoechea-Castano A. Fisterra Guías Clínicas: Somatizaciones en Pediatría. 2017. https://www.fisterra.com/guias-clinicas/somatizaciones-pediatria/#27110
Enlace

Barrio-Alonso M, Conejero-Gómez R, Craven-Bartle Coll A, Martín-Cañuelo J, García-Turrillo E, Laxe-García S, Morales-Mateu A, Torrequebrada-Giménez A, Benito-Penalva J, Cívicos-Sánchez N, Jauregui-Abrisqueta ML, Montoto-Marqués A, Juan-García FJ, Rodríguez-Piñero M. Consenso sobre la profilaxis y tratamiento de la enfermedad tromboembólica venosa en la lesión medular y en el daño cerebral adquirido. Angiologia. 2016 May;68(3):227–34. DOI: 10.1016/j.angio.2015.10.013. IF2016: N/A. http://linkinghub.elsevier.com/retrieve/pii/S0003317015002217
Enlace

Blanco-Barca Ó, Amado-Puentes A, Repáraz A, Melcón C, Torreira C. [Spinocerebellar ataxia-27: description of the clinical phenotype of two twin sisters with a deletion in the FGF14 gene]. Rev Neurol. 2016 Mar;62(5):238–9. PMID: 26916329. IF2016: 0.743; Q4. http://www.ncbi.nlm.nih.gov/pubmed/26916329
Enlace

Caruncho HJ, Brymer K, Romay-Tallón R, Mitchell MA, Rivera-Baltanás T, Botterill J, Olivares JM, Kalynchuk LE. Reelin-Related Disturbances in Depression: Implications for Translational Studies. Front Cell Neurosci. 2016 Feb;10:48. PMID: 26941609. DOI: 10.3389/fncel.2016.00048. IF2016: 4.555; Q1. http://www.ncbi.nlm.nih.gov/pubmed/26941609
Enlace

Costa-Arpín E, Pato A, Rodríguez-Regal A, Midaglia L, Yáñez R, Muñoz D, Lorenzo JR, Amigo C, Prieto JM. Clinical response and tolerability of fampridine in clinical practice. Neurodegener Dis Manag. 2016 Apr;6(2):99–105. PMID: 27032814. DOI: 10.2217/nmt-2015-0004. IF2016: N/A. http://www.ncbi.nlm.nih.gov/pubmed/27032814
Enlace

Fernández O, Arroyo R, Martínez-Yélamos S, Marco M, Merino JAG, Muñoz-García D, Merino E, Roque A, Group RS. Long-Term Adherence to IFN Beta-1a Treatment when Using RebiSmart® Device in Patients with Relapsing-Remitting Multiple Sclerosis. Infante-Duarte C (ed.). PLoS One. 2016 Aug;11(8):e0160313. PMID: 27526201. DOI: 10.1371/journal.pone.0160313. IF2016: 2.806; Q1. http://www.ncbi.nlm.nih.gov/pubmed/27526201
Enlace

Fernandez O, Rodriguez-Antiguedad A, Olascoaga J, Oreja-Guevara C, Prieto JM, Mendibe-Bilbao MM, Garcia-Merino JA, Ramio-Torrenta L, Ginestal R, Meca-Lallana JE, Romero-Pinel L, Munoz D, Saiz A, Calles-Hernandez MC, Izquierdo G, Villar LM, Oliva-Nacarino P, Arnal-Garcia C, Comabella M, Brieva L, Arroyo R, Montalban X. Review of the novelties from the 31st ECTRIMS Congress, 2015, presented at the 8th Post-ECTRIMS meeting. Rev Neurol. 2016 Jun;62(12):559–69. PMID: 27270678. IF2016: 0.743; Q4. http://www.ncbi.nlm.nih.gov/pubmed/27270678
Enlace

Fernández-Martínez R, Kokoulina E, Carballido-Araujo E, Garcia-Fuertes I, Gutierrez-Martinez O, Santiago-Lopez F, Vazquez-Batan P. [Clinical usefulness and psychometric properties of the Cambridge Behavioural Inventory]. Rev Neurol. 2016 Nov;63(10):440–6. PMID: 27819401. IF2016: 0.743; Q4. http://www.ncbi.nlm.nih.gov/pubmed/27819401
Enlace

Garcia-Dominguez JM, Muñoz D, Comellas M, Gonzalbo I, Lizán L, Polanco Sánchez C. Patient preferences for treatment of multiple sclerosis with disease-modifying therapies: a discrete choice experiment. Patient Prefer Adherence. 2016 Sep;10:1945–56. PMID: 27713622. DOI: 10.2147/PPA.S114619. IF2016: 1.798; Q2. http://www.ncbi.nlm.nih.gov/pubmed/27713622
Enlace

Guijarro-Castro C, Sanchez-Zapardiel E, Munoz D, Fernandez O, Leyva L, Castro-Panete MJ, Picon-Munoz C, Talise M, Martinez-Feito A, Paz-Artal E. Month of birth, HLA-DRB1*15 locus and risk of multiple sclerosis in offspring. Rev Neurol. 2016 Sep;63(5):201–5. PMID: 27569565. IF2016: 0.743; Q4. http://www.ncbi.nlm.nih.gov/pubmed/27569565
Enlace

Lo TL, Warden M, He Y, Si T, Kalyanasundaram S, Thirunavukarasu M, Amir N, Hatim A, Bautista T, Lee C, Emsley R, Olivares J, Yang YK, Kongsakon R, Castle D. Recommendations for the optimal care of patients with recent-onset psychosis in the Asia-Pacific region. Asia Pac Psychiatry. 2016 Jun;8(2):154–71. PMID: 27062665. DOI: 10.1111/appy.12234. IF2016: 0.954; Q4. http://www.ncbi.nlm.nih.gov/pubmed/27062665
Enlace

Lopez de Munain L, Juan-Garcia FJ, Duarte E, Martin-Mourelle R, Rodriguez S, Moraleda-Perez S. [Early pharmacologic treatment with botulinum toxin A in post-stroke spasticity: consensus evidence-based recommendations]. Rev Neurol. 2016 Oct;63(8):363–9. PMID: 27699753. IF2016: 0.743; Q4. http://www.ncbi.nlm.nih.gov/pubmed/27699753
Enlace

López-Cortés R, Formigo J, Reboiro-Jato M, Fdez-Riverola F, Blanco FJ, Lodeiro C, Oliveira E, Capelo JL, Santos HM. A methodological approach based on gold-nanoparticles followed by matrix assisted laser desorption ionization time of flight mass spectrometry for the analysis of urine profiling of knee osteoarthritis. Talanta. 2016 Apr;150:638–45. PMID: 26838453. DOI: 10.1016/j.talanta.2015.06.043. IF2016: 4.162; Q1. http://www.ncbi.nlm.nih.gov/pubmed/26838453
Enlace

Martinez-Lapiscina EH, Arnow S, Wilson JA, Saidha S, Preiningerova JL, Oberwahrenbrock T, Brandt AU, Pablo LE, Guerrieri S, Gonzalez I, Outteryck O, Mueller A-K, Albrecht P, Chan W, Lukas S, Balk LJ, Fraser C, Frederiksen JL, Resto J, Frohman T, Cordano C, Zubizarreta I, Andorra M, Sanchez-Dalmau B, Saiz A, Bermel R, Klistorner A, Petzold A, Schippling S, Costello F, Aktas O, Vermersch P, Oreja-Guevara C, Comi G, Leocani L, Garcia-Martin E, Paul F, Havrdova E, Frohman E, Balcer LJ, Green AJ, Calabresi PA, Villoslada P, IMSVISUAL consortium. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study. Lancet Neurol. 2016 May;15(6):574–84. PMID: 27011339. DOI: 10.1016/S1474-4422(16)00068-5. IF2016: 26.284; D1. http://www.ncbi.nlm.nih.gov/pubmed/27011339
Enlace

Meca-Lallana J, Hernández L, Caminero AB, Girón JM, Cano-Orgaz A, Carcelén-Gadea M, Muñoz D, Durán-Ferreras E, Martín-Hernández J, Sánchez-de la Rosa R, FATIGA Study Group. Fatigue Improvement after Switching Multiple Sclerosis Treatment from Interferon-? to Glatiramer Acetate in Clinical Practice. Eur Neurol. 2016;76(1–2):40–7. PMID: 27376845. DOI: 10.1159/000447630. IF2016: 1.697; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27376845
Enlace

Pato-Pato A, Midaglia L, Costa-Arpin E, Rodriguez-Regal A, Puy-Nunez A, Rodriguez-Rodriguez M, Lopez-Real A, Llaneza-Gonzalez MA, Garcia-Estevez DA, Moreno-Carretero MJ, Escriche-Jaime D, Aguado-Valcarcel ML, Munoz D, Prieto JM, Lorenzo-Gonzalez JR, Amigo-Jorrin MC. [Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in Galicia]. Rev Neurol. 2016 Sep;63(s01):S13–8. PMID: 27658431. IF2016: 0.743; Q4. http://www.ncbi.nlm.nih.gov/pubmed/27658431
Enlace

Sepúlveda M, Armangue T, Martinez-Hernandez E, Arrambide G, Sola-Valls N, Sabater L, Téllez N, Midaglia L, Ariño H, Peschl P, Reindl M, Rovira A, Montalban X, Blanco Y, Dalmau J, Graus F, Saiz A. Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes. J Neurol. 2016 Jul;263(7):1349–60. PMID: 27147513. DOI: 10.1007/s00415-016-8147-7. IF2016: 3.389; Q2. http://www.ncbi.nlm.nih.gov/pubmed/27147513
Enlace

Triñanes Y, Atienza G, Rial-Boubeta A, Calderón-Gómez C, Álvarez-Ariza M, De-Las-Heras-Liñero E, López-García M. [Areas for improvement in the management of depression: perspectives of patients, families and professionals]. Rev Calid Asist. 2016 Dec;31(6):365–72. PMID: 27316547. DOI: 10.1016/j.cali.2016.03.010. IF2016: N/A. http://www.ncbi.nlm.nih.gov/pubmed/27316547
Enlace

Vázquez-Campo M, Maroño Y, Lahera G, Mateos R, García-Caballero A. e-Motional Training®: Pilot study on a novel online training program on social cognition for patients with schizophrenia. Schizophr Res Cogn. The Authors; 2016 Jun;4:10–7. PMID: 28740808. DOI: 10.1016/j.scog.2015.11.007. IF2016: N/A. http://www.ncbi.nlm.nih.gov/pubmed/28740808
Enlace

Villar-Quiles RN, Matías-Guiu JA, Ortega G, González-Suárez I, Oreja-Guevara C, Matías-Guiu J. Analysis of the Relationship between the Month of Birth and Risk of Multiple Sclerosis in a Spanish Population. Eur Neurol. 2016;76(5–6):202–9. PMID: 27721317. DOI: 10.1159/000449246. http://www.ncbi.nlm.nih.gov/pubmed/27721317
Enlace

Álvarez E, Olivares JM, Carrasco JL, López-Gómez V, Rejas J. Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors. Ann Gen Psychiatry. 2015 Jan;14(1):2. PMID: 25632294. DOI: 10.1186/s12991-014-0040-0. IF2015: 1.411; Q3. http://www.ncbi.nlm.nih.gov/pubmed/25632294
Enlace

Emsley R, Alptekin K, Azorin J-M, Cañas F, Dubois V, Gorwood P, Haddad PM, Naber D, Olivares-Díez JM, Papageorgiou G, Roca M, Thomas P, Hargarter L, Schreiner A, EMEA ADHES Group. Nurses’ perceptions of medication adherence in schizophrenia: results of the ADHES cross-sectional questionnaire survey. Ther Adv Psychopharmacol. 2015 Dec;5(6):339–50. PMID: 26834967. DOI: 10.1177/2045125315612013. IF2015: N/A. http://www.ncbi.nlm.nih.gov/pubmed/26834967
Enlace

Fernández Fernández MA, Amado Puentes A. [The importance of being careful with the concepts on autism spectrum disorders]. An Pediatr (Barc). 2015 May;82(5):372. PMID: 25510842. DOI: 10.1016/j.anpedi.2014.09.016. IF2015: 0.773; Q4. http://www.ncbi.nlm.nih.gov/pubmed/25510842
Enlace

Fernandez O, Alvarez-Cermeno JC, Arroyo R, Brieva L, Calles-Hernandez MC, Casanova-Estruch B, Comabella M, Garcia-Merino JA, Ginestal R, Izquierdo G, Meca-Lallana JE, Mendibe-Bilbao MM, Montalban X, Munoz-Garcia D, Olascoaga J, Oliva-Nacarino P, Oreja-Guevara C, Ramio-Torrenta L, Romero-Pinel L, Rodriguez-Antiguedad A, Saiz A, Tintore M, Grupo Post-Ectrims GP-E. Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS Meeting (II). Rev Neurol. 2015 Sep;61(6):271–83. PMID: 26350778. IF2015: 0.684; Q4. http://www.ncbi.nlm.nih.gov/pubmed/26350778
Enlace

Fernandez O, Alvarez-Cermeno JC, Arroyo R, Brieva L, Calles-Hernandez MC, Casanova-Estruch B, Comabella M, Garcia-Merino JA, Ginestal R, Izquierdo G, Meca-Lallana JE, Mendibe-Bilbao MM, Montalban X, Munoz-Garcia D, Olascoaga J, Oliva-Nacarino P, Oreja-Guevara C, Ramio-Torrenta L, Romero-Pinel L, Rodriguez-Antiguedad A, Saiz A, Tintore M, Grupo Post-Ectrims. [Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS meeting (I)]. Rev Neurol. 2015 Sep;61(5):215–24. PMID: 26308843. IF2015: 0.684; Q4. http://www.ncbi.nlm.nih.gov/pubmed/26308843
Enlace

Fernández-Cabanaa M, Jiménez-Féliz J, Alves-Pérez MT, Mateos R, Gómez-Reino I, García-Caballero A. Linguistic analysis of suicide notes in Spain. Eur J Psychiatry. University of Zaragoza; 2015;29(2):145–55. IF2015: 0.711; Q4. http://dialnet.unirioja.es/servlet/articulo?codigo=5171234
Enlace

Flórez G, Casas A, Kreis MKF, Forti L, Martínez J, Fernández J, Conde M, Vázquez-Noguerol R, Blanco T, Hoff HA, Cooke DJ. A Prototypicality Validation of the Comprehensive Assessment of Psychopathic Personality (CAPP) Model Spanish Version. J Pers Disord. 2015 Oct;29(5):707–18. PMID: 25248021. DOI: 10.1521/pedi_2014_28_167. IF2015: 3.515; Q1. http://www.ncbi.nlm.nih.gov/pubmed/25248021
Enlace

Muñoz-García D, Midaglia L, Martinez Vilela J, Marín Sánchez M, López González FJ, Arias Gómez M, Dapena Bolaño D, Iglesias Castañón A, Alonso Alonso M, Romero López J. Associated Inosine to interferon: results of a clinical trial in multiple sclerosis. Acta Neurol Scand. 2015 Jun;131(6):405–10. PMID: 25313094. DOI: 10.1111/ane.12333. IF2015: 5.559; Q2. http://www.ncbi.nlm.nih.gov/pubmed/25313094
Enlace

Olivares JM, Álvarez E, Carrasco JL, Pérez Páramo M, López-Gómez V. Pregabalin for the treatment of patients with generalized anxiety disorder with inadequate treatment response to antidepressants and severe depressive symptoms. Int Clin Psychopharmacol. 2015 Sep;30(5):265–71. PMID: 26111356. DOI: 10.1097/YIC.0000000000000087. IF2015: 2.415; Q2. http://www.ncbi.nlm.nih.gov/pubmed/26111356
Enlace

Rivera-Baltanas T, Agis-Balboa RC, Romay-Tallon R, Kalynchuk LE, Olivares-Díez JM, Caruncho HJ. Serotonin transporter clustering in blood lymphocytes predicts the outcome on anhedonia scores in naïve depressive patients treated with antidepressant medication. Ann Gen Psychiatry. 2015 Dec;14(1):45. PMID: 26697099. DOI: 10.1186/s12991-015-0085-8. IF2015: 1.411; Q3. http://www.ncbi.nlm.nih.gov/pubmed/26697099
Enlace

Romay-Tallon R, Rivera-Baltanas T, Kalynchuk LE, Caruncho HJ. Differential effects of corticosterone on the colocalization of reelin and neuronal nitric oxide synthase in the adult hippocampus in wild type and heterozygous reeler mice. Brain Res. 2015 Jan;1594:274–83. PMID: 25451109. DOI: 10.1016/j.brainres.2014.10.050. IF2015: 2.561; Q3. http://www.ncbi.nlm.nih.gov/pubmed/25451109
Enlace

Ruiz MA, Álvarez E, Carrasco JL, Olivares-Díez JM, Pérez M, Rejas J. Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice. Drug Des Devel Ther. 2015 Aug;9(7):4329–40. PMID: 26273194. DOI: 10.2147/DDDT.S88238. IF2015: 2.881; Q2. http://www.ncbi.nlm.nih.gov/pubmed/26273194
Enlace

Spuch C, Antequera D, Pascual C, Abilleira S, Blanco M, Moreno-Carretero MJ, Romero-López J, Ishida T, Molina JA, Villarejo A, Bermejo-Pareja F, Carro E. Soluble Megalin is Reduced in Cerebrospinal Fluid Samples of Alzheimer’s Disease Patients. Front Cell Neurosci. 2015 Apr;9:134. PMID: 25926771. DOI: 10.3389/fncel.2015.00134. IF2015: 4.609; Q1. http://www.ncbi.nlm.nih.gov/pubmed/25926771
Enlace

Triñanes Y, Atienza G, Louro-González A, De-las-Heras-Liñero E, Alvarez-Ariza M, Palao DJ. Development and impact of computerised decision support systems for clinical management of depression: A systematic review. Rev Psiquiatr y salud Ment. 2015 Jul;8(3):157–66. PMID: 25500093. DOI: 10.1016/j.rpsm.2014.10.004. IF2015: 1.65; Q3. http://www.ncbi.nlm.nih.gov/pubmed/25500093
Enlace

Villoslada P, Rovira A, Montalban X, Arroyo R, Paul F, Meca-Lallana V, Ramo C, Fernandez O, Saiz A, Garcia-Merino A, Ramió-Torrentà L, Casanova B, Oreja-Guevara C, Muñoz-García D, Martinez-Rodriguez JE, Lensch E, Prieto JM, Meuth SG, Nuñez X, Campás C, Pugliese M, Study N. Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial. Neurol Neuroimmunol neuroinflammation. 2015 Oct;2(5):e147. PMID: 26405686. DOI: 10.1212/NXI.0000000000000147. IF2015: N/A. http://www.ncbi.nlm.nih.gov/pubmed/26405686
Enlace

Agbemenyah HY, Agis-Balboa RC, Burkhardt S, Delalle I, Fischer A. Insulin growth factor binding protein 7 is a novel target to treat dementia. Neurobiol Dis. 2014 Feb;62:135–43. PMID: 24075854. DOI: 10.1016/j.nbd.2013.09.011. IF: 5.078; Q1. http://www.ncbi.nlm.nih.gov/pubmed/?term=24075854
Enlace

Agis-Balboa RC, Fischer A. Generating new neurons to circumvent your fears: the role of IGF signaling. Cell Mol Life Sci. 2014 Jan;71(1):21–42. PMID: 23543251. DOI: 10.1007/s00018-013-1316-2. IF: 5.808; Q1. http://www.ncbi.nlm.nih.gov/pubmed/?term=23543251
Enlace

Agis-Balboa RC, Guidotti A, Pinna G. 5alpha-reductase type I expression is downregulated in the prefrontal cortex/Brodmann’s area 9 (BA9) of depressed patients. Psychopharmacology (Berl). 2014 Sep;231(17):3569–80. PMID: 24781515. DOI: 10.1007/s00213-014-3567-5. IF: 3.875; Q1. http://www.ncbi.nlm.nih.gov/pubmed/?term=24781515
Enlace

Álvarez-Payero M, Martínez López de Castro N, Ucha Samartín M, Martín Vila A, Vázquez López C, Piñeiro Corrales G. Medication non-adherence as a cause of hospital admissions. Farm Hosp. 2014 Jul;38(4):328–33. PMID: 25137166. DOI: 10.7399/fh.2014.38.4.7660. IF: N/A. http://www.ncbi.nlm.nih.gov/pubmed/?term=25137166
Enlace

Amado-Puentes A, Blanco-Barca Ó, Coll MJ, Sobrido MJ. [Disease due to lysosomal deposits with differential peculiarities: type II GM1 gangliosidosis]. Rev Neurol. 2014 Apr;58(8):382–3. PMID: 24723181. IF: 0.83; Q4. http://www.ncbi.nlm.nih.gov/pubmed/24723181
Enlace

Fernandez O, Alvarez-Cermeno JC, Arnal-Garcia C, Arroyo-Gonzalez R, Brieva L, Calles-Hernandez MC, Casanova-Estruch B, Comabella M, Garcia-Merino JA, Izquierdo G, Meca-Lallana JE, Mendibe-Bilbao MM, Munoz-Garcia D, Olascoaga J, Oliva-Nacarino P, Oreja-Guevara C, Prieto JM, Ramio-Torrenta L, Romero-Pinel L, Saiz A, Rodriguez-Antiguedad A, Grupo Post-Ectrims GP-E. Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I). Rev Neurol. 2014 Sep;59(6):269–80. PMID: 25190340. IF: 0.830; Q4. http://www.ncbi.nlm.nih.gov/pubmed/25190340
Enlace

Fernández Ó, Álvarez-Cermeño JC, Arnal-García C, Arroyo-González R, Brieva L, Calles-Hernández MC, Casanova-Estruch B, Comabella M, García-Merino JA, Izquierdo G, Meca-Lallana JE, Mendibe-Bilbao M del M, Muñoz-García D, Olascoaga J, Oliva-Nacarino P, Oreja-Guevara C, Prieto JM, Ramió-Torrentà L, Romero-Pinel L, Saiz A, Rodríguez-Antigüedad A, Grupo Post-ECTRIMS. Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III). Rev Neurol. 2014 Oct;59(8):371–9. PMID: 25297480. IF: 0.830; Q4. http://www.ncbi.nlm.nih.gov/pubmed/25297480
Enlace

Fernández Ó, Álvarez-Cermeño JC, Arnal-García C, Arroyo-González R, Brieva L, Calles-Hernández MC, Casanova-Estruch B, Comabella M, García-Merino JA, Izquierdo G, Meca-Lallana JE, Mendibe-Bilbao M del M, Muñoz-García D, Olascoaga J, Oliva-Nacarino P, Oreja-Guevara C, Prieto JM, Ramió-Torrentà L, Romero-Pinel L, Saiz A, Rodríguez-Antigüedad A, Grupo Post-ECTRIMS. Revisión de las novedades presentadas en el XXIX Congreso del Comité Europeo para el Tratamiento e Investigación en Esclerosis Múltiple (ECTRIMS) (II). Rev Neurol. 2014 Oct;59(7):307–16. PMID: 25245875. IF: 0.830; Q4. http://www.ncbi.nlm.nih.gov/pubmed/25245875
Enlace

González-Suárez I, Aguilar-Amat MJ, Trigueros M, Borobia AM, Cruz A, Arpa J. Leukoencephalopathy due to oral methotrexate. Cerebellum. 2014 Feb;13(1):178–83. PMID: 24068485. DOI: 10.1007/s12311-013-0528-1. IF2014: 2.717; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24068485
Enlace

Kokoulina E, Fernández R. Maltrato físico y emocional en la infancia y conducta suicida en el adulto. Rev Psicopatología y Psicol Clínica. 2014 Aug;19(2):93–103. DOI: 10.5944/rppc.vol.19.num.2.2014.13060. IF: N/A. http://dialnet.unirioja.es/servlet/extart?codigo=4829647
Enlace

López Fernández JC, Masjuan Vallejo J, Arenillas Lara J, Blanco González M, Botia Paniagua E, Casado Naranjo I, Deyá Arbona E, Escribano Soriano B, Freijo Guerrero MM, Fuentes B, Gállego Cullere J, Geffners Sclarskyi D, Gil Núñez A, Gómez Escalonilla C, Lago Martin A, Legarda Ramírez I, Maciñeiras Montero JL, Maestre Moreno J, Moniche Álvarez F, Muñoz Arrondo R, Purroy García F, Ramírez Moreno JM, Rebollo Álvarez Amandix M, Roquer J, Rubio Borrego F, Segura T, Serrano Ponza M, Tejada García J, Tejero Juste C, Vidal Sánchez JA. Análisis de recursos asistenciales para el ictus en España en 2012: ¿beneficios de la Estrategia del Ictus del Sistema Nacional de Salud?. Neurol (Barcelona, Spain). 2014 Sep;29(7):387–96. PMID: 24035294. DOI: 10.1016/j.nrl.2013.06.017. IF: 1.381; Q4. http://www.ncbi.nlm.nih.gov/pubmed/24035294
Enlace

Lopez M, Olivares JM, Berrios GE. Pellagra encephalopathy in the context of alcoholism: review and case report. Alcohol Alcohol. 2014 Jan;49(1):38–41. PMID: 23926211. DOI: 10.1093/alcalc/agt070. IF: 2.889; Q1. http://www.ncbi.nlm.nih.gov/pubmed/?term=23926211
Enlace

Midaglia L, Dieguez-Varela C, Banegas S, Campos-García S, Muñoz-García D. Buscando una herramienta para la detección precoz de deterioro cognitivo en esclerosis múltiple [Looking for a tool for early detection of cognitive impairment in multiple sclerosis]. Rev Española Investig Oftalmológicas. 2014 Mar;4(1):3–7. IF: N/A. http://www.arke144.com/reiof-2014-vol-4-n-1.html
Enlace

Midaglia L, Pato-Pato A, Rodriguez-Constenla I, Santos-Armentia E, Cimas-Hernando I, Lopez-Fernandez M, Munoz-Garcia D, Valeiras-Munoz C, Lorenzo-Gonzalez JR. Paraparesia espástica tropical: un informe de un nuevo caso en España [Tropical spastic paraparesis: a report of a new case in Spain]. Rev Neurol. 2014 Jun;58(12):573–5. PMID: 24915034. IF: 0.830; Q4. http://www.ncbi.nlm.nih.gov/pubmed/24915034
Enlace

Ortolano S, Vieitez I, Agis-Balboa RC, Spuch C. Loss of GABAergic cortical neurons underlies the neuropathology of Lafora disease. Mol Brain. 2014 Jan;7:7. PMID: 24472629. DOI: 10.1186/1756-6606-7-7. IF: 4.902; Q1. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3917365&tool=pmcentrez&rendertype=abstract
Enlace

Ortolano S, Viéitez I, Navarro C, Spuch C. Treatment of lysosomal storage diseases: recent patents and future strategies. Recent Pat Endocr Metab Immune Drug Discov. 2014 Jan;8(1):9–25. PMID: 24433521. IF: N/A. http://www.ncbi.nlm.nih.gov/pubmed/24433521
Enlace

Piñeiro Corrales G, Vazquez Lopez C, Álvarez-Payero M, Vázquez López C, Álvarez Payero M. Efecto del tratamiento farmacológico en el estado nutricional del paciente neurológico [Effect of pharmacologic treatment of the nutritional status of neurologic patients]. Nutr Hosp. 2014 Jan;29 Suppl 2:47–56. PMID: 25077345. IF: 1.040; Q4. http://www.ncbi.nlm.nih.gov/pubmed/25077345
Enlace

Rivera-Baltanas T, Olivares JM, Martinez-Villamarin JR, Fenton EY, Kalynchuk LE, Caruncho HJ. Serotonin 2A receptor clustering in peripheral lymphocytes is altered in major depression and may be a biomarker of therapeutic efficacy. J Affect Disord. 2014 Jul;163:47–55. PMID: 24836087. DOI: 10.1016/j.jad.2014.03.011. IF: 3.383; Q2. http://www.ncbi.nlm.nih.gov/pubmed/?term=24836087
Enlace

Fernández Hierro J, Gómez Conde L, Muñoz Rodríguez K. Delirios. In: Rodríguez Cerdeira C (ed.). Manejo clínico de la Psicodermatología (Tomo 1). 1st ed. Editorial Círculo Rojo; 2014. ISBN: 978-84-9076-924-9. http://editorialcirculorojo.com/manejo-clinico-de-la-psicodermatologia/
Enlace

Fernández Hierro J, Gómez Conde L, Muñoz Rodríguez K. Trastornos de la conducta alimentaria. In: Rodríguez Cerdeira C (ed.). Manejo clínico de la Psicodermatología (Tomo 1). 1st ed. Editorial Círculo Rojo; 2014. ISBN: 978-84-9076-924-9. http://editorialcirculorojo.com/manejo-clinico-de-la-psicodermatologia/
Enlace

Triñanes Pego Y, Boubeta Rial A, Álvarez Ariza M, De-las-Heras-Liñero E, Atienza Merino G, López García M. ¿Cómo mejorar la práctica clínica de la depresión?: una aproximación cualitativa [How to improve the management of depression?: a qualitative approach]. Ministerio de Sanidad, Servicios Sociales e Igualdad. Santiago de Compostela: Consellería de Sanidad, Axencia de Avaliación de Tecnoloxías Sanitarias de Galicia (avalia-t); 2014. http://www.sergas.es/Docs/Avalia-t/avalia_t201404CualitativaDepresion.def.pdf
Enlace

Álvarez Ariza M, Atienza Merino G, Ávila González M, González García A, Guitián Rodríguez D, Grupo de trabajo de la Guía de Práctica Clínica sobre el Manejo de la Depresión en el Adulto. Guía de práctica clínica sobre el manejo de la depresión en el adulto. Ministerio de Sanidad, Servicios Sociales e Igualdad. Agencia de Evaluación de Tecnologías Sanitarias de Galicia (avalia-t); 2014. Guías de Práctica Clínica en el SNS: Avalia-t 2013. ISBN: 44444-44444. http://www.sergas.es/Docs/Avalia-t/avalia_t201306GPCdepresion_adulto.pdf
Enlace

Louro González A, De-las-Heras-Liñero E, Atienza Merino G, Triñanes Pego Y, Álvarez Ariza M, González García A, Guitián Rodríguez D, Miembros del Grupo de Trabajo de la GPC sobre el Manejo de la Depresión en el Adulto. Servizo Galego de Saúde. Adaptaciones de la GPC sobre el manejo de la Depresion en el Adulto: Factores de riesgo y diagnóstico. 2014. Revisión 2014. http://www.fisterra.com/guias-clinicas/depresion-adulto/
Enlace

Louro González A, De-las-Heras-Liñero E, Atienza Merino G, Triñanes Pego Y, Álvarez Ariza M, González García A, Guitián Rodríguez D, Miembros del Grupo de Trabajo de la GPC sobre el Manejo de la Depresión en el Adulto. Servizo Galego de Saúde. Guía clínica de Depresión mayor en el adulto: Medidas generales y tratamiento farmacológico. 2014. Revisión: 2014. https://www.fisterra.com/guias-clinicas/depresion-mayor-adulto-medidas-generales-tratamiento-farmacologico/
Enlace

Louro González A, De-las-Heras-Liñero E, Atienza Merino G, Triñanes Pego Y, Álvarez Ariza M, González García A, Guitián Rodríguez D, Miembros del Grupo de Trabajo de la GPC sobre el Manejo de la Depresión en el Adulto. Servizo Galego de Saúde. Guía clínica de Depresión mayor en el adulto: psicoterapia y otros tratamientos no farmacológicos. 2014. Revisión 2014. https://www.fisterra.com/guias-clinicas/depresion-mayor-adulto-psicoterapia-otros-tratamientos-no-farmacologicos/
Enlace